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ABSTRACT 
The use of probiotics and prebiotics has become a popular trend in the food 
industry.  The main goal of this study was to produce a synbiot by encapsulating a 
probiotic and a prebiotic within a matrix that would provide sufficient protection to the 
probiotic against simulated gastric juice (SGJ).  The ability of the probiotic, 
Bifidbacterium adolescentis, to grow on short chain fructooligosaccharides (FOS; DP 2-
8, P95), inulin (DP 2-60, ST), and FOS/inulin mixture (DP 2-60, Syn), as well as glucose 
and a glucose-free maltooligosaccharide (MOS), were evaluated.  Bifidobacterium 
adolescentis had a significantly higher specific growth rate on P95 (0.47 h-1), than 
glucose (0.40 h-1).  Examination of the growth medium containing P95 and MOS by high 
performance anion exchange with pulsed amperometric detection (HPAE-PAD) revealed 
that B. adolescentis utilised the oligosaccharides to the same extent as the 
monosaccharides. 
 Bifidobacterium adolescentis was successfully encapsulated with and without P95 
using extrusion and emulsion methods, at cell concentrations of 8-9 log colony forming 
units (CFU) mL-1.  Capsules formed by the extrusion method with 1.0% alginate (AL), 
4.0% pea protein isolate (PPI) + 0.5% AL, and 4.0% whey protein isolate (WPI) + 0.5% 
AL ranged in geometric mean diameter from 2.0 to 2.2 mm.  Capsules formed by 
emulsion with 4.0% WPI + 0.5% AL had geometric mean diameter of 53 µm.  Extrusion-
based encapsulated probiotics in either PPI + AL or WPI + AL showed improved 
survival in SGJ at pH 2.0 for 2.0 h with log CFU mL-1 reductions of 3.6 and 1.1, 
respectively.  Free cells, AL extrusion-based and WPI + AL emulsion-based encapsulated 
probiotics showed no survival after 30 min in SGJ at pH 2.0.  The addition of 1.0% (w/w) 
P95 to the PPI + AL capsules improved probiotic survival such that 1.0 log CFU mL-1 
reduction was observed.  The amount of P95 encapsulated ranged from 4.0 to 4.4 mg per 
gram of capsules. 
The external surface of the PPI + AL capsules as examined by cold stage scanning 
electron microscopy (cryo-SEM) and atomic force microscopy (AFM) was smooth with 
the presence of pores ranging in diameter from 0.25 to 1.00 µm.  The addition of P95 to 
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the capsules had no significant effect on surface roughness as measured by AFM, but 
significantly increased the external capsule thickness.  The internal structure of the PPI + 
AL capsules examined by cryo-SEM revealed a porous honeycomb-like structure, with 
inner pore diameters ranging between 13.0 and 21.9 µm.  Probiotic cells were found to be 
randomly dispersed on the surface and in the interior of the honeycomb pores.  In 
contrast, the prebiotic was found to be distributed throughout the capsule as observed by 
confocal laser scanning microscopy (CLSM), indicating that it would be readily available 
to the probiotic as a carbon source.  
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1. Introduction 
 
The consumption of probiotics has become widely popular with health conscious 
consumers.  Probiotics are a live microbial supplement that improves the host’s health by 
altering its intestinal flora (Fuller, 1989).  Probiotics have been reported to have several 
health benefits associated with their consumption such as, a decrease in lactose 
malabsorption, a decrease in intestinal infection via competitive exclusion, suppression of 
cancer and a reduced risk of coronary heart disease (Gibson & Wang, 1994a; Kulkarni & 
Reddy, 1994; Agerbaek et al., 1995; Fooks et al., 1999).  Although probiotics have been 
purported as having many health benefits, they must maintain viability during their transit 
through the gastrointestinal tract to reach the colon in a concentration of 107 live cells per 
gram of intestinal contents for the host to experience any of these benefits (Bouhnik, 
1993). Classified as a probiotic, Bifidobacteria, are very sensitive to the low pH of the 
stomach (pH 2.0) and their viability tends to be lost after 30 min of exposure.  Several 
strategies have been investigated to improve probiotic survival such as the use of 
prebiotics, which act as a probiotic growth promoter, along with encapsulation.  
Prebiotics are non-digestible carbohydrates that stimulate the growth of the probiotics 
present in the colon (Gibson & Roberfroid, 1995).  The administration of prebiotics to the 
diet has been proven to increase probiotic numbers when the organisms are already 
present in the colon (Gibson at al., 1995).  There are health benefits associated with 
prebiotic consumption such as the ability to decrease the number of detrimental bacteria 
and increase the number of beneficial bacteria found in the gastrointestinal tract, reduce 
plasma triacylglycerols and provide constipation relief (Delzenne & Roberfroid, 1994; 
Tomomatsu, 1994; Fiordaliso et al., 1995; Gibson & Roberfroid, 1995).  However, 
prebiotics will only increase the number of probiotics already present in the colon.  
Therefore, to increase the survival of supplemented probiotics, encapsulation techniques 
have been studied (Krasaekoopt et al., 2003).  Encapsulation is the process by which a 
bioactive ingredient(s) (e.g., probiotics) is entrapped or coated with a matrix 
material (e.g., protein and/or polysaccharide; Risch, 1995).  Alginate (AL), a linear 
2 
 
heteropolysaccharide of D-mannuronic and L-guluronic acid, is the most popular material 
used in the encapsulation of probiotics because it is biocompatible, inexpensive, and easy 
to use (Krasaekoopt et al., 2004).  However, studies have shown that AL capsules do not 
significantly increase probiotic survival in the presence of simulated gastric juice (SGJ; 
Lee & Heo, 2000; Sultana et al., 2000; Truelstrup-Hansen et al., 2002).  Encapsulation 
offers much promise to the probiotic industry as probiotics are generally selected for their 
ability to survive the low pH of the stomach, however, through successful encapsulation 
the industry can select probiotics based on their health effects. 
The overall goal of this research project was to encapsulate the probiotic, 
Bifidobacterium adolescentis, and a prebiotic within a protein and/or AL mixture that 
could provide sufficient protection to the probiotic against SGJ.  Several objectives were 
established to meet this goal. The first objective of this research project was to investigate 
the effect of wall materials, AL, WPI and PPI (individually and in combination) and the 
size of the microcapsules on the survival of B. adolescentis in SGJ as a function of pH.  
The second objective was to investigate the growth potential of B. adolescentis on a 
commercial oligosaccharide (prebiotic) mixture and to incorporate the prebiotic with the 
best growth potential into the capsules to produce a synbiot.  The final objective was to 
investigate the external and internal structures of the designed capsule and to determine 
the spatial distribution of the prebiotic and probiotic within that design. 
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2. Literature Review 
 
2.1 Probiotics 
2.1.1 Definition 
Probiotics were first defined in 1971 as “organisms and substances which 
contribute to the intestinal microbial balance” (Sperti, 1971).  However, this definition 
includes substances such as antibiotics, so in 1989 a more refined definition was 
established for probiotics as a live microbial supplement which beneficially affects the 
host by improving its intestinal microbial balance (Fuller, 1989).  This definition suggests 
that the organism must be viable in order to be classified as a probiotic.  Fuller (1992), 
suggested this definition be modified such that for an organism to be classified as a 
probiotic it must have the following characteristics: 
1. they retain their viability after being processed on an industrial scale; 
2. they must be stable and viable during use and during long periods of storage; 
3. they must be able to survive the gastrointestinal tract; and 
4. they must create a beneficial affect for the host. 
2.1.2 Classified probiotics 
There are three main genera of bacteria used as probiotics; Lactobacillus, 
Bifidobacterium and Streptococcus (Fuller, 1992).  Other less common bacteria used as 
probiotics belong to the genera Leuconostoc, Pediococcus, Propionibacterium and 
Bacillus.  Some yeasts, Saccharomyces cerevisiae and Candida pintolopesii, and moulds, 
Aspergillus niger and Aspergillus oryzae, have also been used as probiotics in animal 
feed. 
2.1.2.1 Lactobacillus spp. 
Lactobacilli bacteria are large, non-spore forming, gram-positive rods, that have 
anaerobic or microaerophilic respiration (Fooks et al., 1999).  Gram-positive bacteria 
have a thick peptidoglycan layer as part of their cell wall whereas gram-negative bacteria 
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have a thin layer (Alcamo, 1997).  Anaerobic bacteria will not grow in the presence of 
oxygen and therefore an atmosphere devoid of oxygen must be present in order for 
growth.  Microaerophilic organisms are organisms that require a lower concentration of 
oxygen than that found in air.  Lactobacillus bacteria are microaerophilic and are 
commonly used as a starter culture in yogurt production and are the most commonly used 
probiotics in foods (Fuller, 1992).  Lactobacillus species used as probiotics include 
L. delbreuckii subspecies bulgaricus, L. acidophilus, L. casei, L. germentum, 
L. plantarum, L. brevis, L. cellobious, L. lactis and L. reuteri. 
2.1.2.2 Bifidobacterium spp. 
Bifidobacteria are large, gram-positive branch shaped rods that are 
microaerophilic (Fuller, 1992).  The use of Bifidobacteria as probiotics started with work 
done by Tisser, in 1905.  He showed that infants who were breast-fed had Bifidobacteria 
as the dominant organisms in their feces, and he implied that formula-fed infants did not 
(Fuller, 1992).  Bifidobacterium spp. can make up to 25% of the total colonic microflora 
in adults and 95% in infants with the predominant species being B. adolescentis and 
B. longum in adults and B. infantis and B. breve in infants (Gibson & Roberfroid, 1995; 
Gibson et al., 1997). Recent studies showed that there was no difference in the amount of 
Bifidobacteria present in breast-fed and formula-fed infants (Penders et al., 2005).  
However, there was a difference in the amount of pathogenic bacteria present in these 
two infant groups.   Breast-fed infants had 15% less Clostridium difficile and 14% less 
pathogenic Escherichia coli, two organisms known to cause diarrhea.  The difference in 
microflora between the two infant groups may be explained by the type of bifidobacteria 
present (Fuller, 1992).  The bifidobacteria species classed as probiotics are very 
important when assessing the beneficial health effects of these organisms.  Bifidobacteria 
classed as probiotics include, B. adolescentis, B. animals, B. bifidum, B. infantis, B. 
longum and B. thermophilum (Fuller, 1992). 
2.1.2.3 Streptococcus spp. 
Streptococci are small gram-positive cocci that are usually found in pairs or short 
chains (Fooks et al., 1999).  These organisms are facultative anaerobes, meaning they can 
grow in the presence or absence of oxygen (Alcamo, 1997).  Streptococcus salivarius 
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subspecies thermophilus, was first used as a probiotic in sour milk and yogurt, and is still 
commonly used as a started culture for yogurt (Fuller, 1992).  Other Streptococci that are 
classed as probiotics include, S. lactis, S. cremoris, S. diatilactis and S. intermedius (S. 
anginosus) (Fuller, 1992). 
2.1.3 Health benefits 
Many potential health benefits have reportedly been associated with the use of 
probiotics.  Benefits that have been reported with the ingestion of probiotics include a 
decrease in lactose malabsorption, a reduced risk of coronary heart disease, a decrease in 
intestinal and vaginal infections, suppression of cancer, and the production of B vitamins 
(Gibson & Roberfroid, 1995; Fooks et al., 1999; Reid, 2002).  Although these are 
significant health claims, there is much scepticism in this area with research turning 
towards proving efficacy. 
Lactose malabsorption is very common, as it affects over half of the world’s 
population (Fooks et al., 1999).  This condition results from an insufficient activity of 
lactase (β-galactosidase) in the human gut.  Lactase hydrolyzes lactose into glucose and 
galactose. Without this conversion an individual will experience abdominal distension, 
increased flatulence and/or diarrhea.  Lactic acid bacteria produce lactase which has the 
ability to hydrolyze lactose into its monosaccharide components, which are more 
efficiently digested.  Fermented dairy products, such as yogurt, that contain probiotics are 
more easily digested by the majority of the population than non-fermented products, such 
as milk. 
It has been reported that dairy products fermented by probiotics have the ability to 
reduce LDL-cholesterol in humans, and reduce the risk of coronary heart disease 
development (Fooks et al., 1999).  In one case, 58 healthy Danish men were subjected to 
a six week feeding trial where half ingested a fermented milk product that contained the 
probiotic, S. thermophilus, and the other half ingested a placebo (Agerbaek et al., 1995).  
The LDL-cholesterol levels in the probiotic fed group were reduced by 10% when 
compared to the control.  The HDL-cholesterol and triacylglycerol levels were similar for 
both groups. 
The administration of probiotics has been reported to reduce pathogenic bacteria 
populations in the colon, which may result in a reduction of intestinal infections.  The 
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gastrointestinal tract contains up to 1012 live bacteria cells per gram of intestinal content, 
therefore, competition arises between microbial species for nutrients and colonization 
(Gibson & Wang, 1994a).  Some bacteria can produce an inhibitory effect against others 
in order to increase their chances of survival.  Several Bifidobacteria spp. have been 
proven to have such an effect.  In a study by Gibson & Wang (1994a), it was shown 
that eight species of Bifidobacteria, B. bifidum, B. adolescentis, B. angulatum, 
B. catenulatum, B. breve, B. infantis, B. longum and B. pseudolongum were able to inhibit 
the growth of the following pathogenic bacteria in vitro: Vibrio cholera, Shigella sonnei, 
Listeria monocytogenes, E. coli, Campylobacter spp., Salmonella spp., Clostridium 
perfringens and Bacteroides fragiles.   
Colon cancer is one of the leading causes of cancer deaths in the United States.  
Probiotics have been associated with the prevention of this disease.  In a study by 
Kulkarni & Reddy (1994), B. longum was fed to rats in order to observe its effect against 
azoxymethane-induced preneoplastic lesions such as aberrant crypt foci, which have been 
associated with colon cancer.  The study concluded that the feeding of B. longum 
inhibited aberrant crypt focci formation by 53%, indicating preventative potential.  In 
another study, the feeding of B. longum to humans for five weeks resulted in a decrease 
in the proportion of bacteriodes and lecithinase-negative clostridia found in the 
participant’s feces (Benno & Mitsuoka, 1992).  Lecithinase-negative clostridia species 
have been found to constitute a high proportion of fecal microflora in colon cancer 
patients and have been implicated in the formation of carcinogens from bile acids. These 
two studies (Kulkarni & Reddy, 1994; Benno & Mitsuoka, 1992) indicate that there is 
definite potential for some probiotic species to aid in the preventation of colon cancer. 
Bifidobacteria have the ability to produce water-soluble vitamins such as 
thiamine, nicotinic acid, folic acid, vitamin B12 and biotin (Deguchi et al., 1985; Noda et 
al., 1994).  Bifidobacterium bifidum and B. infantis were able to synthesize thiamine, 
nicotinic acid and folic acid in significantly higher concentrations whereas other species, 
such as B. breve and B. longum produced these vitamins in lower concentrations 
(Deguchi et al., 1985).  In contrast, B. adolescentis was not able to produce any of these 
vitamins.  B. bifidum and B. adolescentis were able to produce a large amount of biotin 
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extracelluarly, 158.0 and 27.4 g L-1 respectively, when grown in media containing 
isomaltooligosaccharides. 
There are many potential health benefits associated with the use of probiotics, 
most being preventative in nature.  However, more research must be conducted in order 
to confirm these health claims and understand the roles of probiotics in the human diet. 
2.1.4 Challenges associated with probiotic use 
There are documented challenges associated with the consumption of probiotics 
because viability must be maintained in order for them to have a beneficial effect.  For 
this to occur they must arrive at the colon at a concentration of 107 live cells per gram of 
intestinal content (Bouhnik, 1993).  However, the human body is designed to prevent 
illness by reducing the amount of foreign bacteria present in the gastrointestinal tract.  
The low pH of the stomach can negatively affect the amount of viable probiotics that can 
reach the colon.  One study using a dynamic model of the stomach and small intestine 
indicated that after 110 min in the gastric compartment, viable counts for S. thermophilus 
and L. bulgaricus were less than 1%, 60% for L. acidophilus and 80% for B. bifidum 
(Marteau et al., 1997).  Bile salts in the small intestine can also play a destructive role 
with viable counts reaching the colon of less than 10% for S. thermophilus and 
L. bulgaricus, 15% for L. acidophilus and 30% for B. bifidum.  The majority of 
bifidobacteria are especially sensitive to acidic conditions.  When initial counts of 8 log 
CFU mL-1 of B. breve and B. longum were exposed to SGJ at a pH between 1.5 and 2.0 
for 30 min the bacteria experienced a 6 and 7 log CFU mL-1 reduction in numbers, 
respectively (Lee & Heo, 2000; Picot & Lacroix, 2004).  In contrast, B. bifidum cell 
counts decreased by 4.75 log units after exposure to SGJ at pH 2.5 for 1 h and showed no 
surivival after 2 h (Guerin et al., 2003).  Bifidobacterium adolescentis, B. breve, B. lactis 
and B. longum were exposed to SGJ at pH 2.0 for 30 min and all strains were reduced by 
5 log CFU mL-1, where initial counts were approximately 8 log CFU mL-1 (Truelstrup-
Hansen et al., 2002).  The acid resistance of B. lactis  decreased only 1 log unit after 
being exposed to SGJ at pH 2 for 2.0 h, but did not survive after being exposed to SGJ at 
pH 1.0 for 1 h (Favaro-Trindade & Grosso, 2002).  Lorca & de Valdez (2001) found that 
L. acidophilus grown in a media with an uncontrolled pH (4.5) in comparison to a 
controlled pH (pH 6.0) had increased acid tolerance when the bacteria reached their 
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stationary phase.  Protein profiles of the more acid tolerant strain showed an over 
expression of 16 proteins, 7 were expressed as a result of the stationary phase and 9 were 
expressed as a result of a drop in culture pH.  This approach could help determine acid 
resistant strains by their protein profiles in response to the stationary phase of growth.  
Because probiotics are sensitive to the low pH of the stomach, they must be protected in 
some fashion in order to reach the colon in sufficient numbers to exert a beneficial effect. 
Probiotic viability also decreases during product processing and storage (Mattila-
Sandholm et al., 2002).  When probiotics are subjected to freeze drying or spray drying 
their viability decreases. Therefore, the selection of a strain that will withstand processing 
is also very important.  In yogurt, a 78% decline in the population B. longum after 30 d of 
storage at 4 ˚C has been reported (Adhikari et al., 2000).  Another problem associated 
with probiotics is their ability to adhere to the intestinal wall.  Bouhnik et al. (1992), 
showed that the recovery rate of Bifidobacterium spp. in the feces of human volunteers 
was consistent with their percent survival (approximately 30%) during transit through the 
gastrointestinal system, indicating that the bifidobacteria were not effectively adhering to 
the intestinal wall.  The authors observed that after ending probiotic administration their 
presence in feces also stopped.  If the bacteria do not adhere to the colon wall their ability 
to produce beneficial health effects may be compromised.  These problems can be strain 
specific and can be mitigated with screening in order to find a suitable strain. However, 
health benefits are also strain specific, therefore the identification of resistant and health 
promoting probiotic may be difficult, and different methods to increase probiotic survival 
are investigated.  Using different methods other than strain selection for probiotic 
survival will allow researchers to incorporate strains that have greater associated health 
properties.  Prebiotics can be used to increase the growth potential of the probiotic in the 
gastrointestinal system and increase its viability during storage.  Encapsulation provides 
an additional means for improving the viability of probiotics, due to the protective effect 
of their wall materials.  
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2.2 Prebiotics 
2.2.1 Definition 
Prebiotics were defined by Gibson & Wang (1994b) as “a non-digestible food 
ingredient that beneficially affects the host by selectively stimulating the growth and/or 
activity of one or a limited number of bacteria in the colon, and thus improves host 
health”.   Food ingredients that pass though the upper part of the digestive system without 
being absorbed or hydrolysed by human enzymes are referred to as colonic foods.  
Colonic foods act as nutrients for endogenous colonic bacteria and indirectly provide the 
host with energy, metabolic substrates (short chain fatty acids), and essential minerals.  
Prebiotics are colonic foods but not all colonic foods are prebiotics. 
For a food ingredient to be classified as a prebiotic it must meet the following 
criteria (Gibson & Roberfroid, 1995):  
1. it cannot be hydrolysed or absorbed in the upper part of the digestive system; 
2. it must cause the growth and/or activation of one or a limited number of beneficial 
colonic bacteria by being a selective substrate; 
3. it must be able to change the microflora of the colon to a healthier composition; and 
4. it must induce beneficial luminal or systemic effects to the health of the host. 
2.2.2 Ingredients used as prebiotics 
Food ingredients considered to have prebiotic qualities are some non-digestible 
carbohydrates (oligo and polysaccharides), some peptides and proteins, and some lipids 
(Gibson & Roberfroid, 1995).  Non-digestible carbohydrates are the most commonly 
used prebiotic because they are naturally occurring and some are able to fulfill all of the 
aforementioned criteria.  Non-digestible carbohydrates include: resistant starch (starch 
which is not hydrolysed in the small intestine), non-starch polysaccharides 
(hemicellulose, pectins, gums), and oligosaccharides (galactooligosaccharides, 
fructoligosaccharides [FOS]) (Gibson & Roberfroid, 1995; van Dokkum & van den 
Heuvel, 2001).   
Oligosaccharides are generally characterized to be comprised of 2-9 
monosaccharides covalently linked together, whereas polysaccharides are more than 9 
monosaccharides in length (Roberfroid, 2000).  However, there are very few naturally 
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occurring polysaccharides that contain less then 25 to 30 monosaccharides, therefore the 
term oligosaccharide is given to carbohydrate polymers ranging in size from 2 to 20-25 
monosaccharides (Lin et al., 1988).  Oligosaccharides are water-soluble and have 
relatively low sweetness values of 0.3 to 0.6, where sucrose has a value of 1.0 (Crittenden 
& Playne, 1996).  Their sweetness depends on their monosaccharide composition and 
structure.  Oligosaccharides are considered to be good bulking agents because they have a 
low relative sweetness, and their high molecular weight improves product viscosity and 
mouthfeel.  Oligosaccharides are commonly used in the production of low caloric and 
diabetic foods. 
Methods used to produce non-digestible oligosaccharides are: (1) hot water 
extraction of roots (Roberfroid, 2000), such as inulin extraction from chicory 
root; (2) enzyme hydrolysis of oligosaccharides or polysaccharides such as 
xylooligosaccharide production by the action of xylanase on pectin; and (3) the use of 
osyl-transferases, which can be used to synthesize oligosaccharides from a mixture of 
disaccharides such as FOS production from sucrose. 
2.2.2.1 Fructooligosaccharides 
Fructooligosaccharides or oligofructose is the only oligosaccharide that meets all 
prebiotic criteria (Gibson & Roberfroid, 1995).  FOS consists of β-(1→2) glycosidic 
bonded β-D-fructose moieties (Figure 2-1; Roberfroid, 2000) that can have two 
structures, one consisting of all fructose moieties and the other having a terminal D-
glucose α-(1→2) linked to a fructose molecule.  Inulin is the main polysaccharide for 
FOS production and is naturally found in chicory and Jerusalem artichoke roots 
(Roberfroid, 2000).  FOS can be produced by inulin hydrolysis with acid or inulase and 
from sucrose using osyl-tranferases. 
The growth of most bifidobacteria species are found to be improved when FOS 
was used as the carbohydrate source but not when inulin was used.  In a study by Rossi et 
al. (2005), it was observed that of the 55 strains of bifidobacteria studied, the majority 
(52) were able to utilize FOS as a carbon source whereas only 8 could utilize inulin.  
Species belonging to B. longum, and B. animalis had increased growth rates when 
cultured in media containing 1.0% (w/v) FOS (degree of polymerization, DP 2-4) and 
Raftilose™ (DP 2-8, glucose + fructose + lactose < 6.8%), when compared to their 
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Figure 2-1  Structure of fructooligosaccharide with a terminal glucose, n = 1 – 9 
(adapted from Gibson & Roberfroid, 1995).   
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growth rates with inulin (Bielecka et al., 2002).  Eight species of bifidobacteria, 
B. infantis, B. catenulatum, B. pseudolongum, B. longum, B. angulatum, B. breve, 
B. bifidum and B. adolescentis were grown in media containing branched FOS (average 
DP = 13, 8% branching), FOS (average DP = 4), inulin (average DP = 10) and glucose.  
Each of the organisms perferred FOS over the other carbon sources with the exception of 
B. bifidum which grew best in the presence of glucose (Gibson & Wang, 1994b).  The 
inability of B. bifidum to ferment FOS was reported by Kaplan & Hutkins (2000).  In 
their study the  growth rate of B. adolescentis, B. breve, B. bifidum, B. infantis, and 
B. longum on De man, Rogosa Sharpe plates (MRS) containing 2.0% (w/v) FOS and 
30 mg bromcresol purple per liter (which creates a yellow zone around the colonies if the 
carbohyrate was fermented) showed that only B. bifidum was not a FOS fermentor. 
2.2.2.2 Galactooligosaccharides 
Galactooligosaccharides (Figure 2-2) are composed of β-D-galactose units that 
are bonded through β-(1→6) glycosidic linkages with a terminal α-(1→4) linked glucose 
(Roberfroid, 2000).  This group of oligosaccharides are produced from lactose with osyl-
tranferases.   
Bifidobacterium infantis, B. lactis and B. longum were found to have 
higher growth rates (0.131 h-1, 0.091 h-1 and 0.116 h-1, respectively) when 
galactooligosaccharides were used as the main carbon source when compared to those for 
glucose of 0.058 h-1, 0.075 h-1 and 0.095 h-1, respectively (Vernazza et al., 2006). 
2.2.2.3 Maltooligosaccharides  
Maltooligosaccharides or glucooligosaccharides are composed of α-D glucose 
molecules bonded through α-(1→4) glycosidic linkages (Crittenden & Playne, 1996).  
They are produced by treating starch molecules with isoamlyase or pullanase to destroy 
the branch points followed by treatment with α-amylase to hydrolyze the α-1-4 linkages 
to produce oligosaccharides of various lengths.   
Maltooligosaccharides are generally considered to have the ability to promote the 
growth of bifidobacteria in the human colon (Crittenden & Playne, 1996).  Research has 
shown that a diet rich in a maltotetraose enriched corn syrup reduced the level of 
Clostridium perfringens in the colon (Crittenden & Playne, 1996).  In a study observing 
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Figure 2-2  Structure of galactooligosaccharides, n = 1-9 (adapted from Roberfroid, 
2000). 
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the growth of five Bifidobacteria strains (B. adolescentis, B. infantis, B. lactis, and two 
strains of B. longum) where maltooligosaccharides were used as the sole carbon source, 
only B. lactis showed growth (0.041 h-1), whereas all others showed minimal (0.009 h-1) 
or no growth (Vernazza et al., 2006).  However, to be considered a prebiotic, 
oligo/polysaccharides must be able to reach the colon, and maltooloigosaccharides are 
generally digested in the small intestine. 
2.2.2.4 Pectin  
Pectin is composed of α-(1, 4)-linked D-galacturonic acid and its methyl ester 
(Figure 2-3).  Pectin can be classified as high or low methoxy depending on the degree of 
esterification (Walter, 1991).  High methoxy pectin has a degree of esterification greater 
than 50%, whereas low methoxy pectin has less than 50%.  Pectin is a major byproduct 
from the juice industry, however little research on the prebiotic effect of this 
carbohydrate has been conducted.  Some bifidobacteria are able to grow on low methoxy 
(8% degree of esterification) pectin but not on high methoxy (66% degree of 
esterificaiton) pectin (Olano-Matrin et al., 2002; Guerin et al., 2003).   
2.2.3 Health benefits 
Prebiotics have been associated with several health benefits.  Some of the more 
scientifically studied include an increase of beneficial bacteria and a decrease 
in detrimental bacteria located in the gastrointestinal tract, increased absorption of 
minerals/cations, reduced plasma triacylglycerols, and constipation relief (Delzenne & 
Roberfroid, 1994; Tomomatsu, 1994; Fiordaliso et al., 1995; Gibson et al., 1995). 
Fructooligosaccharides and inulin have been found to increase bifidobacteria 
numbers and to reduce those of harmful bacteria in the human colon (Gibson et al., 
1995).  As an example, eight participants were subjected to a 45 d study where they 
consumed 15 g of sucrose per day for 15 d, then 15 g of FOS (Raftilose, DP 2-8) or inulin 
(Raftiline, average DP of 10) was administered for the next 15 d.  For the last 15 d of the 
trial, FOS or inulin was substituted with 15 g of sucrose per day.   The subjects’ bowel 
habits, transit time, stool composition and predominant genera of stool bacteria were 
measured.  The authors found that both FOS and inulin increased stool frequency by 14%  
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Figure 2-3  Structure of pectin (adapted from Walter, 1991). 
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and 34%, respectively.  The participant’s stool microflora was measured, and the authors 
found that both FOS and inulin increased bifidobacteria numbers from 8.8 to 9.5 log g 
stool-1 to 9.2 to 10.1 log g stool-1, while bacteroides, clostridia and fusobacteria numbers 
decreased.  The authors concluded that the consumption of dietary FOS or inulin could 
improve intestinal health and help prevent constipation (Gibson et al., 1995).  Roberfroid 
(2000) reported that in a large majority of studies where prebiotic oligosaccharides were 
administered, increases in bifidobacteria numbers rarely exceeded 0.5 of a log unit, with 
the average population in the feces before treatment ranging from 9.5 to 10 log CFU g-1, 
and reaching a maximum of 10.5 log CFU g-1 after treatment.  This observation questions 
the physiological significance of prebiotic consumption. 
The use of prebiotics has also been associated with better absorption of divalent 
cations in the colon (Gibson & Roberfroid, 1995).  This was confirmed in rat studies, 
where a diet that contained FOS or inulin was found to improve intestinal uptake of the 
minerals Ca2+, Mg2+ and Fe2+ by 60–65% (Delzenne & Roberfroid, 1994).  If the same 
results could beobserved in humans, then a diet rich in FOS or inulin could possibly 
increase the efficiency of mineral absorption, alleviating Fe2+ and Ca2+ deficiencies. 
High plasma triacylglycerols and cholesterol increase an individual’s risk of 
developing coronary heart disease, a leading cause of death in North America.  FOS has 
been shown to have a positive effect in reducing plasma triacylglycerols, phospholipids 
and cholesterol (Fiordaliso et al., 1995).  As an example, rats on a diet containing 10% 
FOS showed reduced plasma triacylglycerols (25% decrease), phospholipids (15% 
decrease) and cholesterol (15% decrease).  Therefore, a diet rich in FOS may lower 
plasma triacylglycerol levels, reducing the risk of developing coronary heart disease.  
Although, FOS and inulin have been associated with health benefits, very little work has 
been done with other prebiotic oligosaccharides.  More research is needed in this area to 
clearly establish the health benefits of these compounds and to determine if the health 
effects observed in animal studies are also found in humans. 
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2.2.4 Challenges associated with prebiotic use 
There are a few documented problems associated with prebiotic consumption.  
The major one is that over consumption of FOS can cause diarrhea, flatulence and 
abdominal discomfort (Crittenden & Playne, 1996).  It has been reported that the 
minimum dose of FOS that causes diarrhea is 40 – 50 g per day (Crittenden & Playne, 
1996).     
2.3 Synbiots 
Synbiots are defined as “a mixture of probiotics and prebiotics that beneficially 
affect the host by improving the survival and implantation of live microbial dietary 
supplements in the gastrointestinal tract, by selectively stimulating their growth and/or by 
activating the metabolism of one or a limited number of health-promoting bacteria and 
thus improving welfare” (Gibson & Roberfroid, 1995).  Probiotics and prebiotics can be 
administered as separate entities or they can be combined (synbiot) in forms such as 
microcapsules. 
2.3.1 Benefits of synbiots 
The combination of prebiotics with probiotics could produce several nutritional 
benefits (Gibson & Roberfroid, 1995; Poo-Zobel et al., 2002; Rastall & Maitin, 2002) 
including: an increase in the survival rate of live bacteria in food products, increased 
protection against colon cancer, an increase in the number of viable bacteria that reach 
the colon, increased growth and implantation of the bacteria in the colon and an increase 
in the metabolic activation of these bacteria.  In Japan, a legal standard of 107 viable 
probiotic cells per milliliter is required in fresh dairy products such as yogurt 
(Krasaekoopt et al., 2003).  The pH of yogurt ranges from 4.2 to 4.6, which is too low for 
most bifidobacteria to remain viable, and they will lose their viability within the first 
week of storage (Adhikari et al., 2000).   
2.4 Encapsulation 
Encapsulation is the process by which a bioactive ingredent(s) is entrapped or 
coated with a wall material (Risch, 1995).  If the particle size formed by encapsulation is 
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between 0.2 to 5000 m then the process is referred to as microencapsulation (Risch, 
1995).  However, the definition of what makes a capsule a microcapsule is not well 
defined, and all capsules, microcapsules and not will be refered to as caspules.  The 
material to be coated or entrapped can be a liquid, solid or gas, can be either living or 
non-living and is referred to as the core material or active ingredient, such as the 
probiotic.  The material that forms the coat is referred to as the wall material, membrane 
or coating.  Wall materials most commonly used for encapsulation of food ingredients are 
hydrocolloids (Roberfroid, 2000; Anal & Singh, 2007).  Hydrocolloids from natural 
sources are used in the food industry and include starch, maltodextrins, gum Arabic, 
cellulosics, agar, gelatin, carrageenans, alginates, low methoxy pectin, whey protein and 
gellan gum (Risch, 1995).   
A common step in the mircoencapsulation process is spray drying; however it is not 
commonly used for probiotics because it causes high cell injury and death.  For example, 
L. rhamnous encapsulated by spray drying in a media that contained 10% (w/v) 
polydextrose resulted in a viability loss of >90% (Corcoran et al., 2003).  However, Picot 
& Lacroix (2004) developed a proceedure whereby probiotics were embedded in milk fat 
and then spray dried with only minimal loss of cell viability. 
Two techniques commonly used for the encapsulation of probiotics are extrusion 
(droplet method) and emulsion (two-phase system) (Krasaekoopt et al., 2003).  In these 
methods the hydrocolloids commonly used are anionic and include carrageenan, alginate, 
low methoxy pectin and gellan gum (Risch, 1995).  
2.4.1 Extrusion 
This method is the oldest and most commonly used technique to make capsules 
with hydrocolloids (Krasaekoopt et al., 2003).  Extrusion is the most popular technique 
used for the encapsulation of probiotics because of its ease, simplicity, low cost and 
gentle formulation conditions that ensures a high retention of viable cells.  The method 
(Figure 2-4 A) involves the preparation of a hydrocolloid solution to which the active 
ingredient is added, and then extruded through a syringe (forming droplets) into a setting 
(cross-linking) solution (Risch, 1995; Krasaekoopt et al., 2003).  Gel spheres form 
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Figure 2-4  Process flow diagram for the encapsulation of probiotics by extrusion (A) and emulsion-based (B) techniques 
(adapted from Krasaekoopt et al., 2003). 
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immediately upon the droplets coming into contact with the cross-linking solution, 
entrapping the core material within a three-dimensional lattice (Krasaekoopt et al., 2003).  
Prebiotics can be incorporated into the capsules by adding them into the hydrocolloid 
solution along with the probiotic and therefore entrapping them together, or by applying 
an additional coating post-capsule formation.  The diameter of the capsules depends on 
the diameter of the syringe, hydrocolloid concentration, solution viscosity and the 
distance between the syringe and the cross linking solution.  
2.4.2 Emulsion 
This technique involves two phases, a discontinuous and a continuous phase 
(Krasaekoopt et al., 2003).  The discontinuous phase contains both the probiotic and the 
hydrocolloid polymer in which the probiotic will be encapsulated, and the continuous 
phase consists of a large volume of vegetable oil such as soybean, canola or corn (Figure 
2-4 B). The discontinuous phase is added to the continuous phase and the two are 
homogenized to form a water-in-oil emulsion.  Tween 80 or another emulsifier is usually 
added to the continuous phase at concentrations of 0.2 and 0.5% to ensure homogeneity 
(Sultana et al., 2000; Truelstrup-Hansen et al., 2002; Krasaekoopt et al., 2003; 
Muthukumarasamy et al., 2006).  Once the emulsion has formed, a cross-linking solution 
is added to precipitate the water-soluble hydrocolloids to form gel particles within the oil 
(Krasaekoopt et al., 2003) and the capsules are phase separated.  The size of the capsules 
is controlled by the speed of agitation and the concentration of the hydrocolloid, and 
typically has a wide distribution range of 25 m to 2 mm. 
Probiotics encapsulated in alginate (AL) by the emulsion technique have not 
generally been shown to significantly improve survivability.  Lactobacillus acidophilus 
and Bifidobacterium spp. encapsulated in 2% AL and 2% Hi-maize™ starch formed by 
the emulsion method ranged in size from 0.5 to 1 mm and did not improve probiotic 
survival as the viability numbers for the encapsulated cells were similar to those of the 
free cells (Sultana et al., 2000).  Four bifidobacteria species were microencapsulated in 
1% AL using the emulsion technique (Truelstrup-Hansen et al., 2002) to produce two 
capsule sizes with geometric means of 19 and 67 m.  The capsules contained 
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approximately 8 log viable CFU mL-1 bacteria cells and were subjected to SGJ at pH 2.0, 
3.0 and 6.0 for 2 h.  The study concluded that encapsulation did not improve the survival 
of the bacteria, as the numbers of surviving cells for the encapsulated bacteria were 
similar to those for free cells.  Whereas, Bifidobacterium infantis and B. bifidum were 
encapsulated in 3% sodium AL by the emulsion method and were protected when 
incorporated in mayonnaise (Khalil & Mansour, 1998).  Encapsulated cell counts 
remained stable in the mayonnaise for 8 to 10 weeks where numbers reached 5.8 and 
5.7 log CFU g-1 for B. bifidum and B. infantis, respectively, whereas free cells decreased 
to 4 log CFU g-1 after 1 week of storage at 5°C.   
2.4.3 Wall materials 
2.4.3.1 Alginate 
Alginate is the wall material most commonly used for the extrusion capsule 
formation method (Krasaekoopt et al., 2003).  AL is a polysaccharide extracted from 
various brown algae and is comprised of monomeric units of -L-guluronic acid (G) and 
-D-mannuronic acid (M) (Figure 2-5; Sabra & Deckwer, 2005).  AL can be composed 
of G and M units in three different ways: a) homopolymeric G blocks, b) homopolymeric 
M blocks, or c) heteropolymeric G-M blocks where G and M sequences are randomly 
arranged either as alternating G-M units or as short interchanging G and M blocks 
interspersed by individual G and M units.  All three blocks types may be present within a 
single AL molecule.  The gel forming properties of AL is largely dependent on the block 
structure and chain length of the molecule.  AL gels are formed by the addition of cation 
such as Ca2+ in the form CaCl2.  Calcium is the preferred cation and binds preferentially to 
the G units, which creates crosslinks within and between the AL molecules and forms 
what is known as an egg-box model (Sabra & Deckwer, 2005).  Alginates rich in G units 
form strong, dense, and brittle gels whereas ALs rich in M units form soft elastic gels 
Alginate-based capsules formed by extrusion increase the survival of probiotics as 
the polysaccharide concentration and capsule size increase (Chandramouli et al., 2004; 
Lee & Heo, 2000).  Lactobacillus acidophilus was encapsulated by a modified extrusion 
method, where the capsules were formed by syringe injection using compressed air 
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Figure 2-5  Structure of alginate: composed of β-D-mannuronic acid (M) and α-L-guluronic acid (G) (adapted from 
Sabra & Deckwer, 2005). 
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(Chandramouli et al., 2004).  Different AL concentrations, capsule sizes and CaCl2 
concentrations were investigated to determine optimal conditions for the survival of 
L. acidophilus.  This study concluded that cell viability increased as AL concentration 
(0.75-2.0%) and capsule size (200, 450, and 1000 m) increased. There was no 
significant increase in the survivability of encapsulated cells as the concentration of 
CaCl2 (0.1, 0.2 and 1.0 M) increased. Encapsulated L. acidophilus (1.8% AL with a 
capsule size of 450 m) experienced a 3 log reduction in numbers, whereas the free cells 
experienced a 5 log reduction when exposed to SGJ at pH 2.0 for 3 h when initial cell 
counts were 9 log CFU mL-1.  Lee & Heo (2000) performed a similar study where B. 
longum was encapsulated by extrusion using syringe/compressed air; AL concentrations 
(2, 3 and 4%) and capsule size (1.03, 1.75 and 2.62 mm) were studied in order to observe 
their effects on probiotic survival in SGJ.  Free cells and cells entrapped in 2% AL, with 
initial cell numbers of 9 and 6 log CFU mL-1 respectively, were all dead after 2 h, 
whereas cells entrapped with 3% AL were reduced to 2 log CFU bead-1 (initial count 6.5 
log CFU bead-1) and 7 log CFU bead-1 for cells entrapped in 4% AL (initial count 7.5 log 
CFU bead-1), under the same conditions.  Although the extrusion method is capable of 
increasing the survival of probiotics in numbers high enough to produce a beneficial 
health effect, it is not practical on an industrial scale because the beads produced are too 
large to be incorporated into foods as they can or may adversely affect texture 
(Truelstrup-Hansen et al., 2002). 
2.4.3.2 Whey protein isolates 
Whey protein isolate (WPI), on average, consists of 90-92% protein, 0.5-1.0% 
lactose, 0.5-1.0% lipid, 2-3% ash and 4-5% moisture (Kilara & Vaghela, 2004).  The 
most abundant protein found in whey is -lactoglobulin, and it comprises about 58% of 
the total protein content and has a molecular weight of 18.3 kDa.  The second most 
prevalent whey protein is -lactalbumin with a molecular weight of 14.1 kDa.  Other 
proteins found in WPI are bovine serum albumin, immunoglobulins and proteose 
peptones.  Proteose peptones are defined as the proteins that remain soluble after the milk 
has been heated at 95C for 2 h and acidified to pH 4.7. 
 24 
 
The formation of a gel (or wall matrix) with whey protein first involves, the 
unfolding of protein molecules followed by the formation of a three-dimensional ordered 
aggregate (Jost, 1993).  Whey proteins are heated at 80-85C for 15-30 min at pH 7 to 
induce denaturation and polymerization into higher molecular weight soluble aggregates, 
creating a turbid and low viscosity solution (whey protein concentration of ~4%).  The 
heat-denatured solution is cooled to room temperature, and the addition of NaCl or CaCl2 
results in gel formation (Hongsprabhas & Barbut, 1997).  The cations bind to the pre-
heated whey proteins causing further protein modification, which causes the aggregates 
to form a network or a gel.  Gelation of the heat-treated whey protein occurs more slowly 
with the use of NaCl than with CaCl2 (Bryant & McClements, 2000).  A possible reason 
for this is that Ca2+ ions are more effective at screening protein electrostatic interactions 
than Na+, and that Ca2+ ions are capable of forming ion-bridges between negatively 
charged amino acids on protein molecules. 
Whey protein isolates have been shown to increase the survival of probiotics in 
SGJ by either the addition of the isolate to the bacterial culture or as a wall material for 
encapsulation.  Bifidobacterium infantis was subjected to SGJ at pH 2.0 for 3 h in the 
presence of 1 g L-1 WPI (Charteris et al., 1998).  The presence of WPI significantly 
improved survivability when compared to bacteria incubated in SGJ without WPI.  
Lactobacillus rhamnosus was encapsulated by extrusion using a 70:30 mixture of 12% 
WPI:bacteria via injection through a 23 gauge needle into a setting solution (16.7% 
CaCl2, 0.1% peptone and 0.04% Tween 20).  The capsules were droplet-shaped, opaque 
and had a diameter of 2.8 mm.  This material was subjected to a dynamic gastrointestinal 
model which varied in pH from 4.4 to 2.0 over 90 min (Reid et al., 2005).  Entrapped 
cells experienced a 2.4 log CFU mL-1 reduction in viability when initial numbers were 
6.2 log CFU mL-1 and the free cells experienced a 4 log CFU mL-1 reduction.  
Bifidobacterium breve and B. longum were encapsulated in 10% WPI by spray drying 
(Picot & Lacroix, 2004).  Free cells and encapsulated cells were subjected to SGJ at pH 
1.9 for 30 min where initial cell counts were around 8 log CFU mL-1.  Cell numbers for 
encapsulated and free cells for B. breve after 30 min were 2 and 1 log CFU mL-1, 
respectively, and less than 1 log CFU mL-1 for both the encapsulated and free B. longum 
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cells.  Although these processes increased probiotic survival they did not do so at 
numbers sufficient to likely create a beneficial health effect to the host. 
2.4.3.3 Pea protein isolates 
Pea protein isolate (PPI) is composed of 88-92% protein, 0.5% lipid, 4-6% ash, 
and 4-5% carbohydrate (Franco et al., 2000).  The major globular proteins in pea protein 
isolate are legumin (11S) and vicilin (7S) (Ducel et al., 2004).  Legumin has a molecular 
weight of 330 kDa and an isoelectric point (pI) of 4.8 (Derbyshire et al., 1976), whereas 
vicilin has a molecular weight of 150 kDa and a pI of 5.5 (Bastista et al., 2005).  For pea 
proteins to form a gel structure they must unfold exposing functional groups, such 
sulfhydryl or hydrophobic moieties (Batista et al., 2005).  No research results have been 
published using pea protein as a wall material for probiotic/synbiot encapsulation. 
2.5 Imaging techniques 
To gain a better understanding of how the process of encapsulation improved 
probiotic protection to SGJ, researchers have used capsule/core material imaging 
employing microscopy techniques such as scanning electron microscopy (SEM), atomic 
force microscopy (AFM), and confocal laser scanning microscopy (CLSM).  These 
techniques offer the visualization of the external and internal structure and substructures 
of the capsules.  In the following sections these imaging techniques are briefly reviewed, 
along with selected applications related to their use in elucidating capsule morphology. 
2.5.1 Scanning electron microscopy 
Scanning electron microscopy offers advantages over other microscopy techniques 
such as transmission electron microscopy (TEM) as the sample size can be much larger 
and images have a greater depth of field.  SEM uses electrons to create an image, 
therefore the specimen under investigation must be conductive.  However, most 
biological materials are good insulators and will build up charge if not coated, thus 
creating a distorted image (Dykstra, 1992).  To make a specimen conductive it is coated 
with a very thin layer (100 Å) of gold or palladium using a sputter coater (Dykstra, 1992).  
A sputter coater consists of a vacuum chamber, a noble-metal-plated cathode (gold or 
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palladium) and an anode.  The specimen is placed on the anode and a vacuum is created 
within the chamber.  Once the vacuum (10-3 Torr) has been achieved a high voltage field 
is created between the cathode and the anode.  For the current to pass between the 
cathode and the anode an inert gas, such as argon, is released into the chamber.  The 
electron flow results in ionization of the argon gas and these ions are accelerated by the 
electron field and travel towards the cathode.  The argon ions hit the cathode at high 
speed dislodging metal atoms that collect on the surfaces inside the chamber, coating the 
specimen.  Once the specimen is conductive it can be imaged using SEM.  A SEM 
system is comprised of  an electron gun, condenser lenses, deflector coils, a detector and 
an amplifier (Figure 2-6; Dykstra, 1992).  The electron gun produces an electron beam by 
applying a voltage to a filament, such as tungsten, causing it to heat up and release 
electrons.  The electrons accelerate towards an anode, producing a beam of electrons.  
The condenser lenses are electromagnetic and focus the electron beam on a small surface 
segment of the specimen.  The deflector coils cause this electron beam to move across the 
specimen’s surface.  When the electron beam hits the specimen’s surface secondary 
electrons are dislodged and travel to the striking collector.  The collector counts these 
electrons and sends a signal to an amplifier and a final image is created by the number of 
electrons emitted from each segment of the specimen via a cathode ray tube (CRT).  The 
more electrons produced the brighter the image, indicating height, and the fewer electrons 
produced the darker the image, indicating depth. 
When imaging with conventional SEM the specimen is imaged under a vacuum 
and must be free of water. Therefore, a specimen must be dried prior to analysis by 
conventional SEM.  Unfortunately, drying can result in structural changes to a specimen.  
Moss et al. (1989) found that when wood fibres present in paper pulp were air-dried prior 
to SEM they completely collapsed, and underwent shrinkage and distortion.  In another 
study, calcium-AL microcapsules fixed with glutaraldehyde followed by dehydration in 
an ethanol series were examined (Allan-Wojtas et al., 2008).  Results showed that these 
microcapsules were not comparable to those that were not dehydrated.  Therefore 
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Figure 2-6  Schematic of an SEM showing the Wehnelt assembly with filament 
(A), anode aperture (B), electron beam (C), condenser lenses (D), 
deflector coils (E), deflector coils (L), cathode ray tube (CRT) (M), 
specimen (F) on stage (G), and electrons (I), striking collector (H), 
amplifier (J), and feeding voltage (K) (adapted from Dykstra, 1992). 
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conventional SEM makes it difficult to observe a specimen’s natural structure in an 
aqueous state. 
2.5.2 Cold stage scanning electron microscopy (cryo-SEM) 
Cold stage or low temperature scanning electron microscopy can be used to image 
a specimen in an aqueous environment.  This technique involves the rapid diffusion of 
heat out of a specimen, instantaneously stopping biological activity (fixing the sample) 
by subjecting the specimen to extremely cold (<-150°C) temperatures (Dykstra, 1992).  
However, when freezing, damage to the specimen’s cellular structure can occur when 
water crystallizes.  Ice crystal growth begins with a nucleation point where water from 
the surrounding medium migrates towards it.  Solute concentrations in regions between 
ice crystals increase as they grow and continue until solute concentrations are sufficient 
to prevent it.  Ice crystal development in cells are bounded by the cell membrane, 
meaning they will not grow larger than the cell (Hagler, 1988).  Ice crystal formation is 
thought to occur in living organism between -2 and -80°C (Dykstra, 1992); however, in 
cryo-SEM water within the specimen is rapidly frozen with liquid nitrogen (-196°C), 
eliminating the ability for ice crystals to grow.  One can view the specimen in its entirety 
or the interior of a specimen by fracturing it with a microtome which is referred to as 
freeze-fracture (Dykstra, 1992).  Once the frozen specimen is placed in the SEM chamber 
under a vacuum (10-5 Torr) the ice sublimates off the specimen’s surface.  The sample is 
then coated with gold or palladium as in the case for conventional SEM, and imaged 
under vacuum at cold temperatures (<-150°C). 
Cold stage SEM imaging of calcium-AL capsules containing probiotics allowed 
for detailed observation of the microcapsules in their frozen hydrated state (Allan-Wojtas 
et al., 2008).  Results showed that the microcapsules were spherical in shape and had a 
relatively smooth external surface.  Because cryo-SEM involves the sublimation of ice in 
order to reveal the structure/surface of a specimen, any soluble but non-volatile substance 
may create an artifact.  These solute artifacts were observed by Moss et al. (1989) when 
examining nylon fibres in solutions containing different carbohydrates (D-glucose, D-
xylose and L-arabinose) at different concentrations (50-0.03 mM).  When imaging the 
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nylon fibers using cryo-SEM, those in the carbohydrate solutions showed the presence of 
fibrillar or sheet-like materials, whereas those in distilled water did not.  The presence of 
fibrillar like materials were found to increase as the carbohydrate concentration 
increased.  Miller et al. (1983) used cryo-SEM to examine chloroplasts in distilled water, 
140 mM sucrose and 100 mM NaCl.  They found that the chloroplast’s membrane was 
completely obscured in sucrose but was clearly visible in distilled water.  In addition, the 
chloroplasts in NaCl appeared to be embedded in a network of microfilaments.  These 
results indicate that the presence of microfilaments in a specimen analysed by cryo-SEM 
may be a process artifact.   
2.5.3 Atomic force microscopy (AFM) 
Atomic force microscopy produces topographical images of a sample in a non-
destructive way, making it suitable for studying biological samples (Hansma et al., 1988).  
AFM is a technique that works by scanning a sample with a tip/probe very to close its 
surface (Kaupp, 2006).  While the tip is scanned over the surface of the sample, the AFM 
records interatomic forces between the apex of the tip and the atoms in the sample 
(Hansma et al., 1988).  The major forces created between the moving tip and the sample 
surface are created from van der Waals, electrostatic, hydrophobic, hydrophilic, and 
capillary interactions (Kaupp, 2006). It measures the attractive or repulsive forces 
between the probe and the sample in either a constant height or force mode (Hansma et 
al., 1988).  When AFM measures repulsive forces the tip is in contact with the sample.  
When AFM measures the attractive forces the tip is close to the surface of the sample but 
not in contact. 
All AFM instruments have five essential components: a sharp tip mounted on a 
soft cantilever, a system to sense the cantilever’s deflection, a feedback system to 
monitor and control the deflection of the cantilever, a scanning system that will move the 
sample in a raster pattern with respect to the tip, and a display system that converts the 
data into an image (Rugar & Hansma, 1990).  A simple block diagram of an AFM system 
is shown in Figure 2-7.  The sample to be analysed is mounted on the xyz piezo scanner 
under the probe (Kaupp, 2006).  The probe is a micromachined cantilever with a sharp 
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Figure 2-7 Block diagram of a laser deflection contact AFM (adapted from 
Kaupp, 2006). 
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pyramidal tip at one end that is brought into contact with the sample surface (Rugar & 
Hansma, 1990; Figure 2-8).  Probes made from Si3N4 are thinner and softer and are 
usually used for studying soft biological samples with the contact mode in air and under 
between it and the sample will deviate from the constant force applied creating an error 
signal.  This signal is amplified to generate height images that reflect the surface 
configuration.  The height image represents the vertical translations (z) of the piezo 
scanner needed to eliminate the error signal created as the probe is moved from one place 
to another, elevated surfaces are assigned a brighter contrast relative to lower lying 
surfaces. 
The topography and surface roughness of extrusion-based AL capsules (800 µm 
in diameter) crosslinked with BaCl2 were examined using non-contact AFM 
(Zimmermann et al., 2003).  The AFM images showed that AL capsules that were stored 
in the cross-linking solution had a rougher surface than those washed three times with a 
NaCl solution.  A variety of different extrusion AL-based beads and capsules crosslinked 
with either BaCl2 or CaCl2 were examined using contact AFM (Lekka et al., 2004).  It 
was observed that the Ba2+-AL beads had a sponge-like surface which was not observed 
for the Ca2+-AL beads.  It was also observed that the Ca2+-AL capsules had much less 
variation in their surface profile than the Ba2+-AL capsules.   
2.5.4 Confocal laser scanning microscopy (CLSM) 
The principle of laser scanning microscopy is to scan a segment on an object with 
a finely focused laser to create an image while using a ‘pinhole’ to remove any light that 
is out of focus (Hibbs, 2004a) thereby creating an optical thin section.  With this 
technology one can create images of exceptional resolution and create a 3-dimensional 
representation by collecting optical slices of an object at different focal depths.  CLSM is 
composed of several parts, a conventional light microscope, a laser, a scan head, a 
controller box and a computer (Figure 2-9).  The conventional light microscope produces 
the image by using an objective lens, therefore the quality and resolution of the final 
image depends on the quality of the objective lens (i.e. high numerical aperture lenses 
result in thinner optical sections).  The scan head moves the laser across the sample in a 
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Figure 2-8  Schematic of an AFM probe (adapted from Rugar & Hansma, 1990). 
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Figure 2-9 Simple diagram of how an image is acquired by CLSM (adapted from 
Hibbs, 2004a). 
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rastering motion while the controller or optics box is used to separate light of different 
wavelengths.  The ‘pinhole’ located in the scan head is a crucial part of the CLSM as it 
allows only the in-focus light through, physically rejecting any out-of-focus light.  The 
light is detected by photomultiplier tubes.  The computer and the controller box are 
required for capturing the image and microscope. 
Confocal laser scanning microscopy creates an image by scanning across the 
sample with a diffraction-limited point of excited light (created by the laser) in a rastering 
motion (Hibbs, 2004a; Figure 2-9).  The scanning pattern is achieved using two mirrors, 
one that scans at a high speed in the x-axis direction and the other scans at a slower speed 
in the y-axis direction.  The irradiated light will excite the naturally or applied 
fluorophores within the sample that match at the wavelength of the laser.  Fluorescent 
light emitted back towards the objective from the sample is separated from the light of a 
second fluorophore or unwanted reflected excitated light by dichroic mirrors.  Dichroic 
mirrors are designed to allow the passage of light of a specific wavelength, or range of 
wavelengths.  Therefore, with the use of dichroic mirrors a researcher can choose which 
wavelength to image if a sample contains two or more fluorophores, or to eliminate 
background fluorescence.  The in-focus light that passes through the dichroic mirrors will 
pass through the ‘pinhole’ and be detected by the photomultiplier tube.  The signal 
created by the detector is converted to a digital form, and the image is displayed in 
greyscale but can be suitably coloured. 
2.5.4.1 Fluorescence 
To view samples with CLSM they must contain a fluorophore that can be excited 
with a laser.  There are many commercially available fluorescent tags that allow one to 
label a large array of chemical and biological compounds (Hibbs, 2004b).  Reactive 
fluorophores, for example fluoresceinamine (FA) and Texas red sulphonyl chloride, are 
commonly used to label antibodies, proteins, lipids and carbohydrates.  There are also 
fluorophores, such as acridine orange and propidium iodide (PI), for labelling nucleic 
acids.  Due to the large variety of fluorescent tags available it is important for the 
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researcher to understand what they are trying to image and choose the appropriate 
compound. 
2.5.4.1.1 Fluoresceinamine I (FA) 
Fluoresceinamine I is a fluorophore that is excited at 490 nm and emits at 530 nm, 
and is commonly used to label carbohydrates (Arnosti et al., 2000; Figure 2-10).  
Fluoresceinamine I has been used to label polysaccharides such as alginic acid, xylan, 
and maltodextrins (De Belder & Granath, 1973; Arnosti et al., 2000; Arnosti, 2003).  
Carbohydrates with reducing ends can be derivatized with FA to create a fluorescently 
labelled molecule.  A method for derivatizing a reducing carbohydrate with FA is the 
reductive animation reaction (Borch et al., 1971).  This method involves the reaction of 
the carbonyl group on a reducing carbohydrate with the primary amino group of FA to 
form a Schiff’s base (Figure 2-10).  The resulting Schiff’s base is reduced to a secondary 
amine with sodium cyanoborohydride (NaCNBH3).   
2.5.4.1.2 Propidium Iodide (PI) 
Propidium iodide is nucleic acid stain that binds to DNA and RNA (Truernit & 
Haseloff, 2008).  Once the dye is bound to the nucleic acids of the sample its 
fluorescence is increased 20-30 fold and the fluorescence excitation and emission 
wavelengths shift 30-40 nm to the red and 15 nm to the blue, respectively (Arndt-Jovin & 
Jovin, 1989).  When PI is bound to nucleic acids its excitation maximum is 535 nm and 
the emission maximum is 617 nm, and can be accomplished with a xenon or mercury-arc 
lamp or with the 488 nm line of an argon-ion laser.  
Propidium iodide stains cells where their cellular membrane has been 
compromised or is permeable, therefore the cells must not be viable in order for the stain 
to move across the cellular membrane and stain the nucleic acids.  Cells can be killed by 
employing a mild chemical/heat treatment in order to ensure that they do not lyse 
releasing their nucleic acids into solution.  Subjecting bacteria to 70% ethanol at 4°C has 
been used in the case of E. coli (Hahn et al., 2008), however in the case of Bifibacterium, 
simply exposing the cells to oxygen (21%) is sufficient to induce death (Simpson et al.,  
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Figure 2-10  Reductive amination of glucose using fluoresceinamine I and NaCNBH3 (adapted from Borch et al., 1971). 
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2005).  Researchers have used PI to enumerate the number of dead microbes within 
bacterial suspensions (Apajalahti et al., 2003).     
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3. Material and Methods 
3.1 Materials 
The following materials were generously supplied for this research project.  
Dextrose equivalent sryup (DE-36) was provided by Archer Daniels Midland (Decatur, 
GA).  Orafti® P95 (P95) [FOS, DP 2-8 (6.8% D-glucose + D-fructose + sucrose)]; 
Orafti® ST (ST) inulin [DP 2-60 (1.3% glucose + fructose, 5.7% sucrose)]; and Orafti® 
Synergy1 (Syn) [FOS/inulin mixture, DP 2-60 (8.3% D-glucose + D-fructose + sucrose)] 
were supplied by ORAFTI S.A. (Oreye, Beligum).  Pea protein isolate (PPI) [82% 
protein, 2.5% fat, <4.0% ash, values reported by supplier] was supplied by Nutri-Pea 
Limited (Portage la Prairie, MB).  Whey protein isolate (WPI) [97.7% protein, 
0.4% lipid, 1.8% ash, values reported by supplier] was supplied by Davisco (Le Sueur, 
MN). 
The following materials and chemicals were purchased from Sigma-Aldrich 
(Oakville, ON): alginic acid sodium salt from brown alginate (AL) medium viscosity 
(batch # 035K0205), dimethyl sulfoxide (DMSO), fluoresceinamine I (FA), D-fructose 
(fructose), D-glucose (glucose), L-cysteine hydrochloride monohydrate (cys), magnesium 
sulfate, maltotriose, maltotetraose, maltopentaose, maltohexaose, maltoheptaose, 
propidium iodide (PI), sodium acetate anhydrous, sodium cyanoborohydride 
(NaCNBH3), Tween 80, and vitamin K1.  
N-butanol, ethyl acetate, glacial acetic acid, potassium dihydrogen orthophosphate 
(KH2PO4), di-potassium hydrogen orthophosohate (K2HPO4), and sodium bicarbonate 
(NaHCO3) were purchased from BDH Inc. (Toronto, ON). 
Calcium chloride dihydrate (CaCl2), hydrochloric acid (HCl), potassium chloride 
(KCl) and sodium phosphate dibasic heptahydrate (Na2HPO4) were purchased from EMD 
Chemicals (Darmstadt, Germany). 
Reinforced clostridial media (RCM), De man, Rogosa, Sharpe (MRS) media and 
yeast extract were purchased from Oxoid Ltd. (Basingstroke, England). 
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Activated carbon, sodium chloride (NaCl) and sodium hydroxide solution (NaOH, 
50% w/w), were purchased from Fischer Scientific (Fair Lawn, NJ). 
Ethanol, 95 and 100% anhydrous, were purchased from Commercial Alcohols Inc. 
(Brampton, ON). 
Bifidobacterium adolescentis ATCC 15703 was purchased from American Type 
Culture Collection (Manassas, VA). 
Bile salts were purchased from Difco Laboratories (Detroit, MI). 
Hemin was purchased from Fluka (Buchs, Switzerland). 
Granulated Difco agar and Bacto™ peptone was purchased from BD (Sparks, MD). 
ProLong was purchased from Invitrogen (Eugene, OR). 
The water used in this research, labelled as ddH2O was produced from a Millipore 
Milli-QTM water system (Millipore Corporation, Milford, MA) unless otherwise stated. 
 
3.2 Study 1: Investigation on the effects of wall material and capsule size on the 
survivability of encapsulated B. adolescentis in simulated gastric juice (SGJ) 
3.2.1 Microorganisms 
Bifidobacterium adolescentis was chosen for this research project because of its 
low acid intolerance and ability to utilise FOS.  Bifidobacterium adolescentis was stored 
at –70 ºC in a 1:1 (v:v) suspension of glycerol and MRS broth.  Cultures were streaked 
onto RCM supplemented with 0.05% (v/v) L-cysteine HCl (RCM-cys) plates at 37 ºC 
under anaerobic conditions (80% N2, 10% CO2 and 10% H2) using an anaerobic chamber 
(Forma Scientific Inc., Marietta, GA). 
3.2.2 Comparison of the growth profile of B. adolescentis in MRS and RCM broths  
Growth experiments were conducted on MRS and RCM broths to determine when 
B. adolescentis reached its stationary growth phase as well as the corresponding cell 
concentration.  Side arm flasks containing 100 mL of MRS or RCM broth were prepared 
according to the manufacturer’s instructions.  Flasks were autoclaved at 121 ºC for 
15 min, supplemented with L-cysteine to 0.05% (v/v) and placed in the anaerobic 
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chamber to equilibrate overnight.  Culture tubes containing 5 mL of sterile MRS or RCM 
broth supplemented with 0.05% L-cysteine (v/v) were inoculated with two isolated 
colonies of B. adolescentis and incubated at 37 ºC under anaerobic condition) for 24 h.  A 
100 μL aliquot was used to inoculate the side arm flasks which were incubated under 
anaerobic conditions for 30 h at 37 °C.  The optical density (600 nm) of the suspensions 
were measured every 40 min for 0-20 h and then every 30 min for 20-30 h by 
spectrophotometry (Novaspec, Biochrom Ltd., Cambridge, England).  Aliquots (100 μL) 
were removed from the flasks, serially diluted with peptone saline (PS; 8.5 g L-1 NaCl 
and 1.0 g L-1 BactoTM Peptone), and spread plated to determine cell counts.  Experiments 
were conducted in duplicate.   
3.2.3 Preparation of B. adolescentis for encapsulation 
Two isolated colonies of B. adolescentis were transferred into RCM-cys broth 
held at 37 ºC under anaerobic conditions.  Cells were harvested after 24 h (stationary 
phase) by centrifugation (1900 x g, 15 min at 4 ºC), washed once with phosphate buffer 
saline (PBS; 0.01 M NaH2PO4, 0.137 M NaCl, 2.68 mM KCl, pH 7.0) and resuspended in 
PS to a final cell concentration of 8-9 log CFU mL-1 determined by pour plate. 
3.2.4 Encapsulation of B. adolescentis in protein and/or alginate 
Wall material solutions prepared for the encapsulation of B. adolescentis included: 
1.0% (w/w) AL, 4.0% WPI + 0.5% (w/w) AL, and 4.0% PPI + 0.5% (w/w) AL.  
Preliminary work creating capsules with the emulsion method showed that 4.0% WPI 
produced capsules with a mean diameter of less than 100 µm, where other concentrations 
(6.0, 8.0 and 10.0%) did not (greater than 400 µm).  Protein isolate concentrations lower 
than 4.0% did not form a stable gel.  AL was added along with the protein isolates in 
order for the capsules to form via the extrusion method.  With AL concentrations greater 
than 1.0% it becomes increasingly difficult to eject the solution through the syringe and 
to bring AL completely into solution. One percent AL and 4% WPI + 0.5% AL were 
prepared by dissolving 0.8 g AL and 3.2 g WPI + 0.4 g AL, respectively, in 80.0 g 
ddH2O.  Solutions were heated at 80 ºC for 30 min in order to denature the protein and 
bring AL into solution and then cooled to 40 ºC in a water bath.  The 4.0% PPI + 0.5% 
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AL was prepared by dissolving 3.2 g PPI in 0.1 M NaOH (~pH 10, required to bring PPI 
into solution) followed by heating at 80 ºC for 30 min in order to denature the protein and 
cooled to 40 ºC in a water bath.  Once cooled, the solution was neutralized to pH 7.0 with 
1.0 M HCl and 0.8 g AL was added. AL was added after neutralization to prevent 
gelation.  The resulting solution was heated at 80 ºC for another 30 min and then cooled 
to 40 ºC in a water bath. The weights of the final solutions were corrected for water loss 
during heating.  
3.2.4.1 Extrusion 
 The capsules were prepared using a modification of the method by Krasaekoopt et 
al. (2003).  A mixture containing 1.0 g (8-9 log CFU mL-1, section 3.2.3) washed 
B. adolescentis cells was mixed with 18.0 g of the 1.0% AL solution and injected through 
a 20G needle (2.0 cm in length) into a filter sterilized cross-linking solution (5.0% (w/v) 
CaCl2 + 1.0% (w/v) Tween 80).  The resulting capsules were allowed to harden in the 
cross-linking solution for 30 min, and were then washed three times with PS.  The 
capsules were either used immediately, freeze dried using a vacuum freeze-dryer 
(Labconco Corp., Kansas City, MO), or left to air-dry overnight (15 h). Percent 
encapsulation of B. adolescentis was ~ 100%.  Experiments were repeated with 4.0% 
WPI + 0.5% AL and 4.0% PPI + 0.5% AL.   
3.2.4.2 Emulsion 
Microcapsules were produced using a modification of the emulsion method of 
Truelstrup-Hansen et al. (2002).  One gram of (8-9 log CFU mL-1) washed 
B. adolescentis cells was mixed with 18.0 g of 4.0% WPI + 0.5% (w/w) AL and was 
added to 100.0 g of canola oil (NoName, Calgary, AB) containing 1.0% (w/v) Tween 80.  
The solution was stirred at 900 rpm for 20 min using an overhead stirrer equipped with a 
square blade paddle (Caframon Ltd., Wiarton, ON) to create a water-in-oil emulsion.  
Thirty-two millilitres of a second emulsion containing 85.0 g of canola oil, 1.0 g Tween 
80, and 17.0 g of 63 mM CaCl2 was added to the first emulsion and stirred (900 rpm) for 
an additional 20 min. The resulting solution was transferred to a separatory funnel and 
40.0 mL of a filter sterilized 5.0% (w/v) CaCl2 solution was added to break the emulsion.  
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The microcapsules produced were allowed to separate from the oil phase, removed, 
washed three times with PS and adjusted to approximately a 1:1 (v/v) ratio of WPI-AL 
capsules to PS.   
Capsules produced by the emulsion method composed of PPI + AL was tried.  
PPI has difficulty separating from the water-oil interface due to the hydrophobic groups 
interacting strongly with the oil phase. 
3.2.5 Analysis of capsule morphology, geometric mean and percent distribution 
Air and freeze-dried extrusion-based capsules were examined by SEM for their 
surface morphologies (Philips, Einthoven, Netherlands) at 20.0 kV.  The capsules were 
specimen mounted using double-sided adhesive tape and coated with gold using a sputter 
coater (Edwards and Philips, West Sussex, England) under vacuum with argon purging.   
Wet microcapsules were sized using a laser scattering particle size distribution 
analyzer (PSA) (Horiban Instruments Inc., Irvine, CA) for size and size distribution. The 
geometric mean diameter of the capsules was recorded instead of arithmetic mean due to 
the non-uniform distribution.  Experiments were performed in triplicate. 
3.2.6 Survival of free and encapsulated B. adolescentis in SGJ 
The survival of free and encapsulated B. adolescentis in SGJ (0.08 M HCl with 
0.2 % (w/v) NaCl; Rao et al., 1989) were studied at pH values (adjusted via the use of 1.0 
and 0.1 M NaOH and HCl) of 6.0, 3.0 and 2.0.  Aliquots of 0.5 mL of the free and wet 
encapsulated cells (8-9 log CFU mL-1) in PS was added to 9.5 mL of SGJ and incubated 
at 37 ºC.  Aliquots of SGJ at pH 6.0 were removed at 20 min time intervals for 2 h, 
whereas for SGJ at pH 3.0 and 2.0, aliquots were removed at 5 min time intervals for the 
first 30 min then at 30 min time intervals until 2 h.  Simulated gastric juice at pH 3.0 and 
2.0 were neutralized with 0.1 M and 1.0 M NaOH, respectively, after being removed 
from the incubator.  Samples containing the encapsulated cells were homogenized (Omni 
Macro Homogenizer, Omni International Inc., Marietta, GA) at a setting of 4.5 for 30 sec 
before being assayed. Preliminary work showed that there was no adverse effect of 
homogenization on cell survival.  Samples were assayed for their cell concentration by 
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serial dilution in PS and pour plating with RCM-cys agar.  The plates were incubated 
under anaerobic conditions at 37 ºC for 48 h.  Detection limit of 1.3 and 2.6 log CFU mL-
1 were established for the free and encapsulated cells respectively, due to the dilution of 
the cells by the addition of the SGJ and the process of encapsulation.  Experiments were 
conducted in triplicate. 
3.3 Study 2: Investigation of the growth potential of B. adolescentis on a selection 
of carbohydrates, and the effect of the encapsulated synbiot on probiotic 
survival in SGJ 
3.3.1 Preparation of glucose-free maltooliogaccharide (MOS) 
A MOS sample was prepared from a DE-36 syrup by charcoal-Celite 
chromatography.  Five grams of the DE-36 syrup was dissolved in ddH2O and added to 
200 g of activated carbon in 600 mL of ddH2O and stirred for 2 h.  The solution was 
vacuum filtered and the carbohydrate-bound carbon was washed with ddH2O until the 
eluted glucose peak area recorded by HPAE-PAD was less than 500,000 mV 
(corresponding to ~2.5% glucose).  Glucose levels were further reduced by washing with 
10% (v/v) ethanol until the peak area of glucose recorded by HPAE-PAD was less than 
50,000 mV (~0.16% glucose).   
The carbohydrate-bound carbon was placed into a 1L beaker containing 900 mL 
of 50% (v/v) ethanol and stirred for 1 h and then vacuum filtered.   The filtered solution 
was evaporated (Buchi, Postfach, Switzerland) and reconstituted with 25 mL of ddH2O.  
Trace glucose was removed by ion exchange chromatography (78 x 300 mm 
SupelcogelTM Ca column; Supelco, Torrance, CA) employing an Agilent 1100 gradient 
chromatography system in series with a refractive index (RI) detector (Agilent 
Technologies Inc., Palo Alto, CA).  The mobile phase was ddH2O at a flow rate of 
0.5 mL min-1 and the sample injection volume was 100 μL.  Oligosaccharides eluting 
from 7.0 to 10.5 min (relative retention time for glucose was 12.0 min) were pooled and 
evaporated to produce MOS (<0.007% glucose w/w).  Data collection and analysis were 
performed using ChemStationTM software (Rev. A.08.03).   
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3.3.2 Comparison of B. adolescentis specific growth rates in a semi-synthetic 
medium containing different carbohydrates 
The fermentation of carbohydrates by B. adolescentis was examined in a semi-
synthetic media (Vernazza et al., 2006) which contained the following (in g L-1): 2.0 
BactoTM peptone, 2.0 yeast extract, 0.1 NaCl, 0.04 K2HPO4, 0.04 KH2PO4, 0.01 MgSO4 
7H2O, 0.01 CaCl2 2H2O, 2.0 NaHCO3, 0.005 hemin, 0.5 bile salts, 2.0 mL L-1 Tween 80 
and 10 μL L-1 Vitamin K.  The media was adjusted to pH 7.0 with 0.1 M NaOH, 
dispensed into screw cap culture tubes (9.0 mL) and autoclaved at 121 ºC for 15 min.  
Media was supplemented with 0.05% (v/v) L-cysteine HCl. 
Two isolated colonies of B. adolescentis were used to inoculate 5 mL of RCM-cys 
broth and then incubated under anaerobic conditions at 37 ºC for 12 h to produce cell 
concentrations of approximately 9 log CFU mL-1.  Aliquots (100 μL) of this cell 
suspension were used to inoculate the semi-synthetic medium, which contained filter 
sterilized 10 g L-1 solutions of glucose, MOS, P95, ST, SYN, or 0.85 g L-1 glucose (Min 
Glu).  Tubes were incubated under anaerobic conditions at 37 ºC for 24 h.  Microbial 
growth was monitored hourly by measuring sample optical density at 600 nm until the 
log phase (~3 h) was reached, at which time readings were taken every 30 min.  Once the 
stationary phase (~7 h) was reached, readings were taken every two hours.  At each 
reading an aliquot of the sample was removed and assayed by serial dilution with PS 
using RCM-cys agar.  Plates were incubated under anaerobic conditions at 37 ºC for 48 h.  
The specific growth rates (µ) were calculated as the slope of the linear/exponential (2 to 6 
h) phase of growth on the log CFU mL-1 vs. time (h) graphs. Experiments were performed 
in triplicate.  
3.3.3 Carbohydrate profile analysis of the semi-synthetic medium containing FOS 
and MOS 
The carbohydrate profile of the semi-synthetic medium containing P95 and MOS 
were analysed by HPAE-PAD before (0 h) and after (24 h) incubation with 
B. adolescentis as outlined above.  The relative retention times of the oligosaccharides 
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present in the samples were determined by comparison those with a maltooligosaccharide 
standard (DP 2-7; 100 mg L-1).  Experiments were performed in triplicate. 
3.3.3.1 High performance anion exchange – pulsed amperometric detection 
(HPAE-PAD) 
A Dionex Bio LC 4000 gradient high performance liquid chromatography system 
equipped with a Dionex PAD (Dionex, Sunnyvale, CA) was used for sample 
carbohydrate analysis.  A Dionex CarboPac PA1 [4 x 250 mm] anion exchange 
column was used in series with a Dionex CarboPac Guard PA-1 [4 x 50 mm] column for 
carbohydrate separation.  Carbohydrate detection was afforded by PAD using the 
following potentials and durations: E1 = 50 mV, T1 = 0.299 s; E2 = 600 mV, T2 = 0.299s; 
E3 = -800 mV, T3 = 0.499 s.  All samples were filtered though a nylon syringe filter 
(13 mm diameter, 0.2 µm pore size; Chromatographic Specialties Inc., Brockville, ON) 
prior to analysis. The injection volume for all analyses was 50.0 μL.  Data analysis was 
accomplished using WMSP Chromatography Manager software WML-2010 (Nangning 
Weimalong Chromatgraph Science Technology Co. LTD, China).  The mobile phase 
consisted of three solvents; solvent A, 100 mM NaOH, solvent B; 100 mM NaOH and 
250 mM Na+CH3COO- and solvent C, 300 mM NaOH.  The gradient program was 100% 
solvent A and after 8 min the percentage of solvent B increased linearly to 100% after 
60 min, followed by a rapid change to 100% solvent C at 61 min.  From 90 to 91 min a 
rapid change to 100% solvent A occurred and was held until 120 min.  The flow rate was 
maintained at 1.0 mL min-1 and the column pressure was approximately 1200 psi. 
3.3.3.2 Synbiot encapsulation with FOS (P95) and its effect on the survival of 
B. adolescentis in SGJ 
Capsules prepared by extrusion were produced as outlined section 3.2.4.1 with the 
addition of 0.19 g P95 to the wall material solution.  The resulting capsules were 
subjected to SGJ at pH 2.0 for 2.0 h under the same reaction conditions as described in 
section 3.2.6.  Capsules were also examined by PSA as described in section 3.2.5.  
Experiments were performed in triplicate. 
 46 
 
3.3.4 Examination of the concentration and type of FOS (P95) encapsulated 
The amount of P95 encapsulated was determined by acid hydrolysis of the cross-
linking solution, the PS wash and the capsules.  Washed capsules (6 g) were added to 
15 mL of 6.0 N HCl, whereas 1.0 mL of the cross-linking solution and the PS wash were 
added separately to 0.5 mL of 6.0 N HCl.  Each of these three solutions were stirred 
overnight (15 h) at room temperature (21 ºC).  The capsule slurry was gravity filtered and 
washed (15 mL ddH2O) and the supernatant, as well as the hydrolyzed cross-linking and 
PS solutions, were individually neutralized to approximately pH 7.0 with 1.0 M NaOH.  
Neutralized solutions were individually analyzed by HPAE-PAD, with an isocratic 
mobile phase of 100 mM NaOH.  The amount of P95 encapsulated was determined by 
comparing the amount of fructose produced by acid hydrolysis (supernatant + cross-
linking + PS wash solutions) to the amount of fructose produced by the acid hydrolysis of 
a range (0.4 to 0.01% w/v) of P95 (correlation coefficient of 0.9964).  Experiments were 
performed in triplicate. 
To examine the type of FOS encapsulated, capsules were gravity filtered and 
washed three times with PS.  The filtered capsules were homogenised (setting 4.5 for 30 
sec) in 30 mL of 1.0 M phosphate buffer, pH 7.0, for 30 sec.  The resulting slurry was 
syringe filtered (0.2 µm) and analysed by HPAE-PAD to determine the type of FOS 
encapsulated. 
3.3.5 Enumeration of B. adolescentis before and after drying 
Capsules containing P95 and live B. adolescentis cells were produced as described 
in section 3.2.4.1.  Counts of B. adolescentis in the wet capsules were determined by the 
homogenisation of 0.5 mL of capsules in 9.5 mL PS, followed by serial dilution in PS 
and pour plating with RCM-cys agar.  For each wall material, the equivalent number of 
air dried (25 ºC for 15 h) or freeze dried (-40 ºC for 15 h) capsules in 0.5 mL of wet 
capsules were used for analysis.  Capsules were added to 9.5 mL aliquots of PS and were 
allowed to resuspend for 1 hr.  The samples were homogenised at a setting of 4.5 for 30 
sec and plated using pour plating with RCM-cys agar after serial dilution with PS.  Plates 
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were incubated under anaerobic conditions at 37 ºC for 48 h.  Experiments were 
performed in triplicate. 
3.4 Study 3: Investigation of the external and internal morphology of the pea 
protein-alginate capsules and determination of the spatial distribution of 
fluorescently-labelled glucose and B. adolescentis within these capsules 
3.4.1 Derivatization of glucose 
Glucose was fluorescently labelled with FA using a modified reductive amination 
procedure (Guttman & Pritchett, 1995).  In brief, 10 µL of a 100 mg mL-1 glucose 
solution was placed in a 500 µL microcentrifuge tube and lyophilized for 1 h.  The 
resulting dried glucose was derivatized by the addition of 100 µL of a 0.4 M FA and 1.0 
M NaCNBH3 mixture in 70:30 (v/v) dimethyl sulfoxide (DMSO):glacial acetic acid 
solution.  The mixture was vortexed for 30 s and placed in a heating block (IncuBlock, 
Denville Scientific Inc, South Plainfield, NJ) at 70 °C overnight (15 h).  Following 
derivatization, the sample was diluted with 800 µL of a 1:1 (v/v) solution of ethanol and 
ethyl acetate and the FA labelled glucose (GLU-FA) was separated from the free FA 
using thin layer chromatography (TLC).  The sample was placed on a preparatory TLC 
plate (20x20 cm, 500 µm thickness, Whatman Int. Ltd., Maidstone, England), developed 
using a mobile phase of 1:1:8 (v/v/v) ethanol:acetic acid:ethyl acetate and visualised by 
UV (200 – 400 nm).  The GLU-FA with a retention factor (Rf) of 0.21 was removed from 
the plate with a sharp knife separating it from the free FA with a Rf of 0.95.  The GLU-
FA was eluted from the silica with 50 mL of a 3:7 (v/v) ethanol:ethyl acetate solution by 
gravity filtration.  The solvent was evaporated (Buchi, Postfach, Switzerland) and the 
resulting solid/liquid was dissolved in 2 mL of a 1:1 (v/v) ethanol:ethyl acetate solution, 
and placed in 2 mL pre-weighed centrifuge tubes.  The solvent was then allowed to 
evaporate in a fume hood (~72 h).  Approximately 4 mg of GLU-FA was recovered.  
Samples were checked for purity using TLC with the aforementioned mobile phase and 
stored in the dark at 4°C until used for encapsulation studies. 
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3.4.2 Labelling of B. adolescentis with propidium iodide (PI) 
Bifidobacterium adolescentis were labelled with PI in order to observe cell 
location/distribution within the PPI + AL capsules.  Five millilitres of B. adolescentis 
cells (~8 log CFU mL-1) in PBS were fixed overnight at 37°C in an oxygenated 
environment to permeabilize the bacterial cell membrane.  Cells were then pelleted by 
centrifugation (1900 x g, 15 min) and resuspended in an aqueous solution of PI (15 nmol) 
for 2 h at room temperature, and then washed with PS (1.0 mL) by centrifugation three 
times to remove any unbound PI. 
3.4.3 Production of pea protein-alginate capsules containing GLU-FA  
Capsules composed of the wall materials 1.0% AL and 4.0% PPI + 0.5% AL were 
prepared as described in section 3.2.4.1.  For examination of carbohydrate distribution, 
7 mg of GLU-FA dissolved in 0.40 g of DMSO was added to the PPI + AL wall material 
solution.  The concentration of the PPI + AL solution was adjusted to account for the 
addition of DMSO to ensure the wall material concentrations were maintained at 4.0% 
PPI + 0.5% AL.  Examinations of prebiotic distribution within the capsules were 
measured in the absence of probiotics.   
3.4.4 Production of pea protein-alginate capsules containing PI-labelled 
B. adolescentis 
Capsules composed of the wall materials 1.0% AL and 4.0% PPI + 0.5% AL were 
prepared as described in section 3.2.4.1.  For examination of probiotic distribution PI, 
labeled B. adolescentis were encapsulated.  Capsules produced were stored at 4°C until 
analyzed. 
3.4.5 Preparation of capsules for confocal laser scanning microscopy 
Capsules studied or examined by CLSM were, PPI + AL, PPI + AL + DMSO, PPI 
+ AL + DMSO + 0.005 M FA, PPI + AL + DMSO + GLU-FA, PPI + AL + PI-labeled 
B. adolescentis.  DMSO was added to the capsules inorder to solubilise the GLU-FA. 
Capsules (1.5 g) were prepared for CLSM imaging by subjecting them to an ethanol 
dehydration series, followed by embedding in paraffin wax, cross-sectioning at 8 µm and 
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mounting on a glass slide as described by Jensen (1962).  The ethanol dehydration series 
consisted of several solution changes with each subsequent solution containing a slightly 
higher concentration of ethanol.  The capsules (1.5 g) were dehydrated in an ethanol 
dehydration series which started with a 10% (V/V) ethanol solution (2.0 mL) followed by 
increases of 10% to a final ethanol concentration of 100% which was repeated three 
times.  Capsules were maintained in each solution for 40 min before a dehydration 
change was made, leaving sufficient solution to cover the capsules.  The resulting 
capsules were left overnight in 100% ethanol.  Dehydrated capsules were incubated at 
60°C and 3-4 chips of paraffin wax were added.  Over the course of 1 d, paraffin wax 
chips (2-3) were added periodically (every 2 h) to increase the liquid volume two fold.  
Samples were incubated at 60°C overnight without lids (3 mL total volume) to afford 
ethanol evaporation.  The wax was decanted and replaced three times with fresh molten 
wax (2.0 mL) to ensure removal of residual ethanol.  The capsules plus wax were poured 
into ceramic dishes (3x5x1 cm) and were allowed to cool and harden at room temperature 
for 48 h.  The capsules were then sectioned at 8 µm using a rotary microtome (Ernst Leitz 
GMBH, Weztlar, Germany) and mounted onto glass slides (75x25x1 mm) coated with 
Myer’s solution (albumin and glycerol, 1:1, v/v).  The sectioned capsules were allowed to 
adhere to the slides overnight. The slides were then placed in xylene overnight to dissolve 
the wax; this step was repeated with fresh xylene.  Coverslips were mounted onto the 
glass slides using ProLong and were imaged by CLSM. 
3.4.6 Confocal laser scanning microscopy 
A Zeiss LSM 410 Confocal Laser Scanning Microscopy system (Zeiss, 
Thornwood, NY), equipped with an argon multiline ion laser (Uniphase 2214-25ML) was 
used to investigate the location and distribution of the GLU-FA and probiotics within the 
PPI + AL capsules.  All confocal fluorescence images were taken with a 10x (numerical 
aperture [N.A.] 0.3 Epiplan-Neofluar) or 40x (N.A. 1.3 Plan-Neofluar) objective.  The 
software used for CLSM imaging was Carl Zeiss LSM version 3.99 (Zeiss).  The laser 
was adjusted to an excitation wavelength of 488 nm.  Emission filter blocks Chroma 
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D515/20 and HQ610/75 were used for the GLU-FA and probiotic imaging, respectively.  
Scale bars were added to the images using ImageJ version 1.38w. 
3.4.7 Cold stage scanning electron microscopy  
One or two capsules of each wall material (AL and PPI + AL) were randomly 
selected and imaged.  Data was reported using 10-20 measurements from an individual 
capsule from 2-3 images and represent as an average measurement ± standard error of 
measurement.  Individual capsules were placed into 2 mm cavities machined into 
2x1x0.5 cm custom made copper mounts which were then plunge-frozen in nitrogen 
slush at -210°C.  The samples were places in the Emitek K1250 cryo preparation 
chamber (Emitek, Ashford, UK) at -170°C and fractured with a precooled sharp blade.  
Samples were transferred under vacuum to the SEM chamber (JEOL, Field Emission 
SEM, Tokyo, Japan) where the temperature was raised to -40°C and surface ice was 
allowed to sublime for approximately 30 min.  Samples were then cooled to -150°C and 
transferred back to the cryo preparation chamber where they were sputter coated with 
about 100 Å of gold and transferred to the SEM chamber maintained at -160°C with an 
acceleration voltage of 5kV.  Images were recorded digitally.   
Pore sizes were determined by measuring the long and short internal axis.  The 
aspect ratio of the pores was determined by dividing the long internal axis by the short 
internal axis. 
3.4.8 Atomic force microscopy 
Capsules (1.5 g) were dehydrated in an n-butanol series prior to examination by 
AFM.  The n-butanol series consisted of several solution changes with each subsequent 
solution containing a slightly higher concentration of n-butanol.  The n-butanol 
dehydration solutions were as follows and in order of addition: A (50 ml H2O/40 mL 
95% EtOH/10 mL n-butanol), B (30 mL H2O/50 mL 95% EtOH/20 mL n-butanol), C 
(15 mL H2O/50 mL 95% EtOH/35 mL n-butanol), D (45 mL 95% EtOH/75 mL n-
butanol), E (35 mL 95% EtOH/75 mL n-butanol) and F (100% n-butanol).  The capsules 
were maintained in each solution for 1 h before a dehydration change was made, leaving 
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sufficient solution to keep the capsules covered.  The final 100% n-butanol dehydration 
was repeated three times and samples were maintained at 4°C until imaged. 
Atomic force microscopy was performed using a PicoSPM Iinstrument (Molecular 
Imaging Corp. Tempe, AZ).  Imaging was carried out using oxide-sharpened silicon 
nitride AFM probes with a tip radius of ca. 10 nm (cantilever nominal spring constant = 
0.12 N m-1; resonance frequency of approximately 26 Hz; Veeco Probes, Camarillo, CA) 
in the contact mode.  The scanning force constant was 60-80 nN and scan rates were 
approximately 1 Hz.  Image areas of 5.0 by 5.0 µm were collected.  The stored images 
were analyzed using PicoScan software, version 5.3.3. (Molecular Imaging Corp.) to 
determine capsule surface roughness.  Six areas of 2.0 by 2.0 µm were selected from each 
capsule image and analyzed to determine the root mean squared surface roughness of the 
capsule.  Data was obtained from two randomly selected capsules of each type. 
The root mean squared roughness (Rrms) is calculated from the equation: 
 
n
n
i ZiZrmsR
   1
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where Zi is the height value of each single data point in the image, Z  is the mean value 
of all the height values in the image, and n is the number of data points in the image. 
3.5 Statistics 
Sample data are presented as the mean ± standard deviation, unless otherwise 
stated.  Statistical significance between samples was determined using the Student’s T-
test (p < 0.05).   
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4. Results and Discussion 
4.1 Study 1: Investigation on the effects of wall material and capsule size on the 
survivability of encapsulated B. adolescentis in SGJ 
4.1.1 Comparison of the growth profile of B. adolescentis in MRS and RCM broths 
Bifidobacterium adolescentis reached stationary growth phase more rapidly in the 
RCM-cys broth than in the MRS-cys broth (Figure 4-1 A, B).  The optical densities of the 
cells indicated that the stationary phase for RCM-cys was reached after 20 h of growth, 
whereas 30 h was required for MRS-cys (Figure 4-1 A).  The viable cell count data 
indicated that B. adolescentis reached the target growth value of approximately 
9 log CFU mL-1 at 20 h of growth for both RCM-cys and MRS-cys broth; these cell 
numbers were maintained for up to 27 h (Figure 4-1 B).  Viable cell count experiments 
were halted after 27 h of growth as numbers had not changed between 20 and 27 h.  For 
RCM-cys broth, the entry into the stationary phase resulted in cell numbers close to the 
target growth value of approximately 9 log CFU mL-1. 
 The importance of producing a cell concentration of approximately 9 log 
CFU mL-1 was based on the delivery of sufficient bacteria to transverse the GI tract and 
reach the colon in numbers large enough to produce a beneficial affect to the host 
(Bouhnik, 1993). It is also important for the bacteria to be in their stationary growth 
phase as it has been shown that the acid tolerance of probiotics increases after entry into 
this growth phase and therefore would have some natural resistance to the acidic 
environment of the stomach (Hartke et al., 1996).  In this study, the stationary growth 
phase for B. adolesecentis was reached at 20 and 30 h for RCM-cys and MRS-cys broths 
respectively. Entry into the stationary phase for both media differed between the 
measurements taken using optical density and cell concentration (Figure 4-1 A,B).  The 
discrepancy was thought a result of the increased sensitivity of the cell concentration 
assay in comparison to the optical density assay.  Because the target cell numbers of 
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Figure 4-1 Optical density (A) and cell numbers (B) for growth curves of 
B. adolescentis in (○) MRS-cys and (●) RCM-cys broths.  Data points 
represent the mean value and the range is represented by the bars. 
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approximately 9 log CFU mL-1 was reached in the RCM-cys stationary phase of growth 
more rapidly (~20 h) it was used as the growth medium for all further studies. 
4.1.2 Capsule geometric mean, surface morphology and size distribution 
Bifidobacterium adolescentis was successfully encapsulated using the modified 
extrusion method of Krasaekoopt et al. (2003), with encapsulated cell numbers averaging 
8.7 ± 0.4 log CFU mL-1 (number of cells added to capsule suspension) or 7.4 ± 0.2 log 
CFU g-1 wet capsules.  Capsule size and percent size distribution were determined using 
PSA and the geometric mean and variance of the capsules, and percent distribution are 
shown in Table 4-1 and Figure 4-2, respectively. Capsules produced via extrusion using 
1.0% AL had a geometric mean diameter of 2.3 mm, and were spherical in shape and 
colourless.  The 4.0% WPI + 0.5% AL capsules had a geometric mean diameter of 2.2 
mm, had a tear drop shape and a white opaque colour (Figure 4-3 F).  The 4.0% PPI + 
0.5% AL were the smallest capsules produced (geometric mean diameter = 2.0 mm) and 
also exhibited the tear dropped shape and had a pale tan opaque colour.  SEM images of 
the freeze- and air-dried capsules revealed that the AL capsules exhibited a rougher, more 
porous-appearing external structure (Figure 4-3 A, B), whereas the WPI and PPI capsules 
had a smoother, less porous external appearance (Figure 4-3 C-F).  Bifidobacterium 
adolescentis was also successfully encapsulated by the emulsion method of Tuelstrup-
Hansen et al. (2002) using AL only, yielding an average number of viable cells of 8.3 ± 
0.2 log CFU mL-1 (section 3.2.3).  This method was successful in reducing the size of the 
capsules to less than 100 µm, with a mean geometric diameter of 53.38 µm and had a size 
distribution ranging from approximately 10 to 350 µm (Table 4-1, Figure 4-2).   
The extrusion method afforded the production of capsules of consistent size and 
relatively uniform size distribution (Table 4-1 and Figure 4-2).  According to literature, 
capsules produced by this method vary in size from 2 to 5 mm in diameter, which is 
controlled by the concentration of the wall material solution, the needle diameter of the 
syringe, and the distance between the syringe and the cross linking solution (Krasaekoopt 
et al., 2003; Anal & Singh, 2007).  The non-spherical tear-drop shape of the protein- 
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Figure 4-2  Particle size distribution (%) determined by particle size analysis of 
capsules produced by extrusion and emulsion methods. 
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Figure 4-3  SEM microgrophs of freeze- (A, D, and E) and air-dried (B, C, and F) 
extrusion based capsules produced with AL (A, B); PPI + AL (C, D); 
WPI + AL (E, F). Magnification at 9.3x. 
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Table 4-1 Geometric mean diameter of capsules produced by extrusion and 
emulsion methods determined by PSA. 
Technique Materialsa Geometric 
Mean 
  (μm) 
Extrusion 1.0% AL 2254 
 1.0% AL with 1.0% P95 2018 
 4.0% WPI + 0.5% AL 2150 
 4.0% WPI + 0.5% AL with 1.0% P95 2054 
 4.0% PPI + 0.5% AL 1990 
 4.0% PPI + 0.5% AL with 1.0% P95 1769 
Emulsion 4.0% WPI + 0.5% AL 53.38 
aalginate (AL), whey protein isolate (WPI), pea protein isolate (PPI) 
 
based capsules (Figure 4-3 F) can be explained by the slower gelation properties of this 
material when compared to AL (Reid et al., 2005).  In order to decrease the diameter of 
the capsules to <100 µm, a modification of the emulsion method of Truelstrup-Hansen et 
al. (2002) was used.  The wall material concentration (4.5%) was higher compared to the 
capsules created by Truelstrup-Hansen et al. (2002).  To reduce the size of the capsules 
the rpm of the stirrer was increased to 900 rpm to decrease the droplet size within the 
emulsion to <100 µm. The size of these microcapsules (~53µm) was below that of 
100 µm which is reported to not adversely affect the texture of foods (Truelstrup-Hansen 
et al., 2002). 
4.1.3 Survival of free and encapsulated B. adolescentis in SGJ 
Free B. adolescentis cells were able to survive for 2 h in SGJ at pH 3.0 and 6.0 
with little (a decline of 1.2 log CFU mL-1 from initial cell numbers), or no reduction in 
cell viability, respectively (Figure 4-4 A, B).  However, free cells were not able to 
survive in SGJ at pH 2.0, as indicated by the rapid drop (7 log CFU mL-1) in cell viability 
after only 10 min (Figure 4-4 C).  Encapsulating B. adolescentis in 1.0% AL by the 
extrusion method did not result in improved cell survival in SGJ at pH 2.0, as cell counts 
were similar to those observed for the free cells (Figure 4-4 C).  Capsules produced using 
either 4.0% WPI or PPI + 0.5% AL aided the survival of B. adolescentis in SGJ at pH 2.0 
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Figure 4-4 Survival of free- and extrusion-based encapsulated B. adolescentis cells 
in SGJ at pH 6.0 (A), pH 3.0 (B) and pH 2.0 (C), detection limit of 1.3 
and 2.6 log CFU mL-1 for free and encapsulated cells, respectively.  
Data represents the mean value ± one standard deviation (n = 3). 
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(Figure 4-4 C).  After 2 h of exposure to SGJ at pH 2.0, B. adolescentis experienced a 1.5 
and 3.6 log CFU mL-1 reduction in numbers for 4.0% WPI + 0.5% AL and 4.0% PPI + 
0.5% AL, respectively.  
The increase in probiotic survival exhibited by the capsules produced by the 
extrusion method may be explained by several factors.  First, structural differences 
between the AL capsules and the protein + AL capsules could help to explain the increase 
in probiotic survival for the protein + AL capsules.  SEM of the AL capsules produced in 
this study showed a very porous and rough external surface (Figure 4-3 A, B).  With 
these large pore sizes (~400 µm; Figure 4-3 A), SGJ could readily diffuse into the AL 
capsules resulting in decreased probiotic survival.  Both of the protein-based capsules had 
a smoother, less porous external surface than the AL capsules (Figure 4-3 C-F).  The 
smoother, less porous external surface of the protein-based capsules may have resulted in 
a slower diffusion of SGJ into the capsules resulting in higher probiotic survival rates.  
Second, the observed increase in probiotic survival for the protein + AL capsules 
may be related to the higher concentration of wall materials used when compared to the 
AL capsules.  The AL capsules were prepared using 1.0% (w/w) AL, whereas the protein 
+ AL capsules were prepared using 4.0% protein + 0.5% AL.  This difference in 
concentration of the wall materials would result in a more dense capsule structure, which 
would be expected to retard the diffusion of SGJ into the protein-based capsules when 
compared to the less dense structure of the AL capsules.  The observed higher survival 
rate for the probiotic in the WPI + AL versus PPI + AL capsules may be explained by the 
higher concentration of protein per gram of wall material for WPI (97%) when compared 
to PPI (82%).  It has been shown that an increase in wall material concentration improves 
probiotic survival for AL (Lee & Heo, 2000).   
Finally, the protein-based capsules in this research were produced using a high 
(0.45 M) CaCl2 concentration which resulted in opaque capsules.  Barbut (1995), found 
that WPI gels produced with a high (>180 mM) CaCl2 concentrations were opaque and 
had lower water holding capacity, when compared to those produced with low 
(<180 mM) CaCl2 concentrations which were transparent.  These differences in water 
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holding capacity could explain the increased survival of the probiotic in protein-based 
(lower SGJ absorption) versus AL (higher SGJ absorption) capsules.   
The emulsion-produced capsules employing 4.0% WPI + 0.5% AL as wall 
materials were unable to provide any protection to the probiotic against SGJ at pH 2.0, as 
the results obtained were similar to those of the free cells (Figure 4-5 C). By decreasing 
the size of the capsules the surface area to volume increases which increases the exposure 
of the capsules to the environment.  Therefore, as the surface area to capsule size 
decreases the ability of the SGJ to diffuse into the capsules increases, decreasing 
probiotic survival.  These results agree with those reported in literature, where alginate 
capsules showed no protection for encapsulated B. longum  and B. lactis at pH 2.0 
(Truelstrup-Hansen et al., 2002).  The emulsion-produced capsules could exhibit 
structural differences to the extrusion-produced capsules that mat increase the ability of 
SGJ to infiltrate the capsules.  However, no structural studies of the emulsion-produced 
capsules was conducted. 
4.1.4 Summary and conclusions 
The use of RCM broth supplement with L-cysteine was able to produce cell 
concentrations of B. adolescentis of approximately 9 log CFU mL-1 in their stationary 
growth phase.  This was important because B. adolescentis in their stationary growth 
phase have the highest acid tolerance, and would be in sufficient concentration to produce 
a beneficial effect to their host upon arrival to the large intestine.   
The type of wall materials used in capsule production was found to have an effect 
on probiotic survival.  The use of pea and whey proteins in combination with AL resulted 
in increased probiotic survival in SGJ at pH 2.0, whereas AL alone showed no added 
protection.  Images of the freeze- and air-dried capsules showed the AL capsules to be 
more porous that the protein-AL capsules.  The use of protein in the wall material 
solution resulted in a smoother, less porous capsule which may have inhibited the 
movement of SGJ into the capsule resulting in increased probiotic survival.  The higher 
wall material concentration in the protein + AL capsules increased probiotic survival as 
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Figure 4-5  Survival of free- and emulsion-base encapsulated B. adolescentis cells 
in SGJ at pH 6.0 (A), pH 3.0 (B) and pH 2.0 (C), detection limit of 1.3 
and 2.6 log CFU mL-1 for free and encapsulated cells, respectively.  
Data represents the mean value ± one standard deviation (n = 3).
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these capsules had a total polymer concentration of 4.5% compared to just 1.0% for Al 
capsules. 
Capsule size was also found to effect probiotic survival.  Capsules produced with 
4.0% WPI + 0.5% AL by emulsion and extrusion had geometric means of 0.054 and 
2.2 mm respectively.  No increase in probiotic survival in SGJ (over free cells) was 
observed for the small capsules, whereas only a 1.0 log CFU mL-1 reduction was 
observed for the larger capsules.  However, structural differences between the emulsion 
and extrusion produced capsules could also help to explain decreases in probiotic 
survival. 
4.2 Study 2: Investigation of the growth potential of B. adolescentis on a selection 
of carbohydrates, and the effect of the encapsulated synbiot on probiotic 
survival in SGJ 
4.2.1 Comparison of B. adolescentis specific growth rates in a semi-synthetic media 
containing different carbohydrates 
The specific growth rate of B. adolescentis was studied on glucose, two 
different FOS samples (P95 and Syn), and an inulin sample (ST).  As shown in Figure 
4-6, B. adolescentis was able to utilize inulin and FOS as a carbon source and had a 
significantly (p < 0.05) higher specific growth rate with P95 when compared to glucose. 
However, all of these commercial samples contained appreciable levels of glucose, 
fructose and sucrose.  For example, 1.3% and 5.7% of the total carbohydrate content (as 
per supplier data) of ST was glucose/fructose and sucrose, respectively.  Therefore, a 
growth study employing the maximum amount of these carbohydrates (8.5%) was 
conducted with glucose (0.85 g L-1).  Bifidobacterium adolescentis was able to grow in 
this medium with a specific growth rate that was not significantly different (p > 0.05) 
from those observed for Glu, ST or Syn.   
A glucose-free maltooligoaccharide (MOS) sample was prepared from a DE-36 
syrup employing both HPAE-PAD and Ca+2 ion exchange chromatography with a final 
monosaccharide content of <0.007%.  The specific growth rate of B. adolescentis with 
MOS was not significantly different from those of glucose and Min Glu (Figure 4-6). 
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Figure 4-6 Specific growth rates of B. adolescentis on different carbohydrate 
samples; Glu (10.0 g L-1 glucose); ST (10.0 g L-1 Orafti® ST); P95 
(10.0 g L-1 Orafti® P95); Syn (10.0 g L-1 Orafti® Synergy1); Neg (no 
carbohydrate); Min Glu (0.85 g L-1 glucose); MOS (10.0 g L-1 glucose 
free maltoooligosaccharide).  Data represents the mean value ± one 
standard deviation (n = 3).  Notations (*) and (**) represent a 
significant change in specific growth rate from glucose and minimal 
glucose, respectively (p < 0.05). 
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The observed ability of B. adolescentis to utilise short chain FOS better than glucose and 
large chain FOS has been observed by others (Gibson & Wang, 1994b; Hopkins et al., 
1998; Kaplan & Hutkins, 2000; Rossi et al., 2005; Vernazza et al., 2006; Huebne et al., 
2007).  However, in all of these published studies, the carbohydrate sources used were 
commercial and contained appreciable levels of monosaccharides (i.e., glucose/fructose) 
which leads to some confusion comparing specific growth rates on these substrates and 
oligosaccharide utilization.  Gibson & Wang (1994b) reported B. adolescentis NCFB 
2230 to have a significantly higher (p < 0.01) specific growth rate (0.27 ± 0.03 h-1) for 
oligofructose (DP 2-4) than for glucose (0.20 ± 0.05 h-1), but no difference was observed 
when inulin (0.20 ± 0.03 h-1, DP of 10) was used as the carbon source when compared to 
glucose.  Huebner et al. (2007) reported that B. adolescentis ATCC# 15706 was able to 
utilise Raftilose® P95 (DP 2-7, 95% FOS) more effectively than inulin.  In contrast, 
Vernazza et al. (2006), reported B. adolescentis DSM20083 had a lower specific growth 
rate on P95 (0.09 ± 0.02 h-1) and a higher specific growth rate on ST (0.24 ± 0.01 h-1) 
when compared to glucose (0.11 ± 0.01 h-1).  Kaplan & Hutkins (2000) investigated the 
specific growth rate of B. infantis 17930 on a purified FOS and demonstrated that the 
growth was in fact due to the utilization of the FOS instead of any appreciable amount of 
monosaccharides found in the commercial sources; however, the pure FOS were added to 
basal MRS broth which contained 2.0% glucose.  It has been reported that the ability and 
the extent of FOS utilization as a carbon source is highly species- and strain-specific, and 
can account for the published differences in specific growth rates observed (Gibson & 
Wang, 1994b; Hopkins et al., 1998; Kaplan & Hutkins, 2000; Rossi et al., 2005; 
Vernazza et al., 2006; Huebner et al., 2007) .   
In the present study, B. adolescentis was able to grow in a low concentration 
(0.85 g L-1) of glucose at a rate that was not statistically different from GLU, ST and Syn.  
These results indicate that the specific growth rate for probiotics in literature may only 
represent the utilization of the monosaccharides present in the FOS samples, rather than 
oligosaccharide utilization.  The prepared MOS material was used to confirm whether 
B. adolescentis was able to utilise oligosaccharides when glucose was present in minimal 
concentrations (<0.007%).  The specific growth rate for MOS indicated that 
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B. adolescentis was able to utilise DP 2-7 oligosaccharides as effectively as glucose with 
rates of 0.34 ± 0.03 and 0.40 ± 0.02  h-1, respectively.   
4.2.2 HPAE-PAD analysis of the carbohydrate profile of the medium containing P95 
(FOS) and MOS before and after incubation with B. adolescentis 
The carbohydrate profile of P95 and MOS before (0 h) and after (24 h) incubation 
with B. adolescentis was determined by HPAE-PAD analysis of the medium (Table 4-2).  
A significant reduction in peak area for select oligosaccharides (DP 3-6) in medium 
containing P95 was observed with ranges of 33.7 to 49.8%, whereas the peak area for 
DP 2 increased by 15.2%.  For MOS, the DP 2-4 oligosaccharides were completely 
utilized whereas DP 5-7 were not utilized at all as their peak areas/heights were virtually 
unchanged (Figure 4-7). 
To confirm that B. adolescentis utilized the oligosaccharides in the samples and not 
just the monosaccharides, the carbohydrate profile of the growth medium containing P95 
at time 0 and 24 h was determined by HPAE-PAD.  The significant reduction in peak 
areas (Table 4-2) for DP 3-6 indicated that B. adolescentis utilized these 
oligosaccharides. The changes observed in carbohydrate peak area also show that 
B. adolescentis did not preferentially utilize a specific DP first.  These results were in 
agreement with those of Rossi et al. (2005) and Ameratti et al. (2006) who reported 
simultaneous utilization of FOS by B. adolescentis MB 239.  The peak area for DP 2 
increased over the 24 h time period indicating its production during probiotic growth as a 
result of the breakdown of longer chain oligosaccharides.  The enzymes inulinase or β-
fructosidase are produced by B. adolescentis in the presence of P95 and cleave off 
fructose moieties from the non-reducing end of the oligosaccharide molecules creating 
shorter chain compounds (McKeller & Molder, 1989).  The use of short chain FOS as a 
prebiotic for encapsulation with Bifidobacterium shows much promise as these organisms 
are able to utilize these compounds as a carbon source with specific growth rates close to 
or better than glucose (Gibson & Wang, 1994b; Hopkins et al., 1998; Kaplan & Hutkins, 
2000; Rossi et al., 2005; Vernazza et al., 2006).  Rossi et al., (2005) reported that out of 
55 Bifidobacterium strains (representing 11 species), 52 were able to utilize FOS as a 
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Table 4-2  Percent change in carbohydrate abundance in P95 after 24 h of 
B. adolescentis cell growth in a basal media containing P95 as the 
carbon source. 
Carbohydratea Mean Relative Retention 
Time (min) 
% Change in peak area after 
24 hb 
F 6.14  -11.5  (5.5) 
DP2 18.90  +15.2  (10.2) 
DP3 24.86  -33.7  (6.2) 
DP4 29.96  -49.8  (4.2) 
DP5 36.22  -42.4  (5.6) 
DP6 45.33  -38.0  (8.3) 
a F, Fructose; G, glucose; DP 2-6 includes FOS with chemical structures of Gα1→2[βF-1→2]n, and [βF-
1→2]n (i.e. DP 3 includes F3 and GF2) 
b – Indicates a decrease in peak area, + indicates an increase in peak area. Standard deviation in brackets (n 
= 3) 
 
 67 
 
 
Figure 4-7  HPAE-PAD carbohydrate elution patterns present at time 0 (A) and 
after 24 h of B. adolescentis growth (B). DP 2 = maltose, DP 3 = 
maltotriose, DP 4 = maltotetraose, DP 5 = maltopentaose, DP 6 = 
maltohexaose (glucose relative retention time ~ 6 min). 
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carbon source, whereas only 8 were able to utilize inulin (average DP of 25).  Since FOS 
are nondigestible carbohydrates, they would transverse the GI tract and reach the colon 
intact and therefore be available to the bacteria for fermentation, whereas 
monosaccharides, such as glucose and fructose would be digested.  The addition of FOS 
into the capsules would not substantially increase the caloric content of foods to which 
this material was added and would provide an appropriate carbon source for probiotic 
growth. 
The HPAE-PAD analysis of the growth media containing MOS confirmed this 
materials ability to be utilized as a carbon source by B. adolescentis (Figure 4-7).  After 
24 h of B. adolescentis growth, the DP 2-4 oligomers, were completely utilized whereas 
the DP 5-7 oligomers were not.  Although the MOS produced and used in this study 
would not be considered to be a prebiotic, it was clearly utilized as a carbon source by 
B. adolescentis. 
4.2.3 Synbiot encapsulation with FOS (P95) and its effect on the survival of 
B. adolescentis in SGJ 
The prebiotic, P95, was successfully encapsulated employing the extrusion method 
(see section 3.2.4.1).  The mean percentage of the initial amount (0.1900 g) of P95 that 
was encapsulated was 13.41 ± 0.64 %, 16.83 ± 1.34%, and 10.87 ± 0.32% for 1.0% AL, 
4.0% WPI + 0.5% AL, and 4.0% PPI + 0.5% AL, respectively (Table 4-3).  Per gram of 
wet capsules, there was 0.0044 ± 0.0001 g, 0.0040 ± 0.0003 g and 0.0044 ± 0.0002 g of 
P95 for 1.0% AL, 4.0% WPI + 0.5% AL, and 4.0% PPI + 0.5% AL, respectively. The 
carbohydrate profile of the encapsulated P95 was examined by homogenizing the 
capsules (5-8 g) in 30 mL of 0.1 M pH 7.0 phosphate buffer for 30 sec.  HPAE-PAD 
chromatograms of a 0.04% P95 standard, and the extracted material from 1.0% AL + P95 
(dilution factor of 10) capsules are shown in Figure 4-8.   
The addition of P95 improved the survival of B. adolescentis in SGJ at pH 2.0 for 
all wall materials (Figure 4-9).  The log CFU mL-1 reduction after 2 h was 1.0 and 1.1 for 
4.0% PPI +0.5% AL and 4.0% WPI + 0.5% AL, respectively.  The addition of P95 did
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Table 4-3 Percent P95 in extrusion-based capsules and supernatant. 
Wall Materiala Encapsulatedb Cross-linking Solution Wash   Total 
1.0% AL  13.41 ±  0.64 68.57 ± 4.20  13.16 ±  1.39  97.94 ±  3.70 
4.0% WPI + 0.5% AL  16.83 ±  1.34 70.11 ± 2.07  14.72 ±  0.85  101.67 ±  4.12 
4.0% PPI + 0.5% AL  10.87 ±  0.32 69.18 ± 2.60  16.32 ±  0.28  98.34 ±  2.04 
aAlginate (AL), Whey Protein Isolate (WPI), Pea Protein Isolate (PPI) 
b Values reported as mean ± SD (n = 3). 
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Figure 4-8  HPAE-PAD carbohydrate profiles for the P95 standard and the 
homogenized 1.0% AL + P95 extrusion-based capsules. (F= fructose, 
DP 2-6 = [βF-1→2]n, n = 2-6). 
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Figure 4-9  Survival of free- and encapsulated B. adolescentis cells with and 
without P95 in SGJ at pH 2.0 for 1.0%AL (A), 4.0% WPI + 0.5% AL  
(B) 4.0% PPI + 0.5% AL (C).  Data represents the mean value ± one 
standard deviation (n = 3). 
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not appear to affect the structure of the capsules, as SEM images of capsules produced 
and without P95 were similar (results not shown).  However the addition of P95 to the 
capsules could have caused some structural changes that were visualized using SEM, 
resulting in an increase in probiotic survival. 
During capsule formation the water solubility of P95 facilitated its migration out 
of the capsules and into the cross-linking solution.  Analysis (HPAE-PAD) of the cross-
linking solution showed significant levels (68-70%) of the original P95 used with a 
further 13-16% in the capsule wash (PS) solution.  The amount of carbohydrate 
encapsulated is important, as it must be sufficient to facilitate probiotic growth upon 
arrival at the colon. The amount of P95 encapsulated in one gram of wet capsules ranged 
from 4.0 to 4.4 mg.  Growth studies from this research indicated that B. adolescentis was 
able to grow in a medium which contained as little as 0.085% carbohydrate (glucose).  
Therefore, one gram of capsules would contain sufficient carbohydrate to facilitate the 
growth of B. adolescentis.  HPAE-PAD results show that the carbohydrate profile of the 
encapsulated P95 was similar to that of the P95 standard, indicating that no molecular 
sieving of this material by the pores present in the AL capsules occurred (Figure 4-8).  
This was also observed for capsules composed of PPI and WPI (results not shown).  
Therefore, B. adolescentis would have direct access to the FOS required for growth and 
proliferation upon arrival into the large intestine if the FOS is available to the bacteria 
and not cross-linked into the wall materials.  The addition of P95 to the capsules may 
have increased the survival of B. adolescentis cells by increasing the physical barrier 
(wall) to SGJ diffusion into the capsule.  The co-encapsulation of probiotics with 
prebiotics (synbiot) has been shown in literature to increase probiotic survival (Chen et 
al., 2005; Iyer & Kailasapathy, 2005). 
4.2.4 Enumeration of B. adolescentis before and after drying 
The moisture content in capsules produced by the extrusion method containing P95 
was reduced by freeze and air-drying to investigate the effect of drying on probiotic 
viability after these treatments.  Freeze-drying resulted in better survival of 
B. adolescentis than air-drying, with cell count of approximately (dried capsule weights 
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not determined) 8.0 ± 0.3 log CFU mL-1 and 6.6 ± 0.3 log CFU mL-1 for the 4.0% PPI + 
0.5% AL capsules, respectively (Figure 4-10). Bifidobacterium adolescentis has been 
reported to have low oxygen tolerance with 24 h of exposure resulting in a 95% reduction 
in cell viability (Simpson et al., 2005).  In this study, the observed significant differences 
in probiotic survival for WPI and PPI + AL versus AL capsules may be explained by the 
structural differences between the protein + AL capsules and the AL capsules (Figure 
4-3).  The addition of protein to the wall material may have provided an increased barrier 
to O2 diffusion.    
4.2.5 Summary and conclusions 
Bifidobacterium adolescentis was able to utilise the commercial FOS and inulin 
sources as well as glucose, with short chain FOS (P95) resulting in the best growth rate.  
It was shown that B. adolescentis was able to grow on the low concentrations of 
glucose/fructose.sucrose (0.085%) present in the FOS sources.  However, the growth of 
B. adolescentis on MOS and analysis of the growth media containing P95 and MOS by 
HPAE-PAD confirmed that the probiotic was able to grow and utilise oligosaccharides.  
A concentration of P95 suitable for probiotic growth was successfully 
encapsulated by the extrusion method.  Analysis by HPAE-PAD also demonstrated that 
the capsule matrix did not result in molecular sieving of the P95, in that the large DP FOS 
were not preferentially encapsulated over the low DP FOS.  The addition of P95 to the 
capsules showed an increase in probiotic survival for the protein + AL capsules.  The 
entrapment of both B. adolescentis and P95 within the protein-AL capsules created a 
synbiot that protected the probiotics from SGJ and could potentially deliver both the 
organism and its carbon source to the large intestine. However, the availability of the 
prebiotic to B. adolescentis was not determined. 
The protein-based capsules showed better survival than AL capsules for the 
probiotic for both drying techniques.  Of the two protein-based capsules, the PPI + AL + 
P95 exhibited the best probiotic protection.  Freeze drying resulted in higher survival 
rates than air drying which was mostly likely due to the decreased exposure to oxygen 
encountered for this technique.  
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Figure 4-10  B. adolescentis cell counts before and after drying in the extrusion-
based capsules containing P95.  Data represents the mean value ± one 
standard deviation (n = 3). 
* Statistically significant (p < 0.05) change in cell viability from air drying in respective wall material. 
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4.3 Study 3: Investigation of the external and internal structures, size and shapes 
of the pea protein-alginate capsules, and determination of the spatial 
distribution of prebiotics and probiotics within these capsules 
4.3.1 Examination of the external surface, size and shape of capsules 
The external surface, size and shape of PPI + AL capsules were examined using 
both cryo-SEM and AFM imaging techniques.  Overall, capsules ranged in size from 1.5 
to 2.0 mm in diameter under cryo-SEM, which were comparable to the values observed 
by particle sizing (~2.0 mm – geometric mean diameter; Table 4-1).  Capsules prepared 
for cryo-SEM imaging maintained their spherical shape with no evidence of structural 
collapse or excessive shrinkage.  This is in contrast to capsules prepared for conventional 
SEM, which resulted in structural collapse (i.e., loss of their spherical structure within the 
native hydrated state) and a more porous surface (Figure 4-3).  Cryo-SEM has been 
shown to maintain structural integrity for a pectin-AL based capsule (Zohar-Perez et al., 
2004; Sriamornsak et al., 2008).  
 The external surface of the PPI + AL capsules appeared smooth and relatively 
non-porous (Figure 4-11 A, C) with the exception of a few tiny black patches on the 
surface (Figure 4-11 B, D).  The latter were presumed to be small pores that ranged in 
diameter from 0.25 to 1.0 m, and occurred regardless of the presence or absence of 
B. adolescentis.  Topographical images by AFM also suggested the presence of external 
pores on the capsules, observed as low-lying areas ranging in diameter from 0.5 
to 1.0 m (Figure 4-12).  Surface roughness or the deviation of the vertical height of the 
capsules surface, as measured by AFM , was found to be 119.02  35.40 nm.  The 
addition of P95 had no significant effects on the external surface morphology or surface 
roughness of the capsules as determined by AFM (76.35  16.49 nm; p > 0.05).  
Scanning electron microscopy of capsules containing B. adolecentis showed 
partially- or completely-exposed bacteria on their surfaces (Figure 4-13).  Exposed 
bacteria had lateral and longitudinal lengths of 0.9 and 1.6-2.3 m, respectively and were 
spatially oriented near or at surface pockets (Figure 4-13).  The presence of bacteria on, 
or integrated within the surface was expected because in capsule processing both the wall 
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Figure 4-11 Cryo-SEM micrographs of the external surface of 4.0% PPI + 0.5% 
AL capsules in the absence (A, B) and presence (C, D) of 
B. adolescentis.  Rectangles indicate the areas in A and C that are 
magnified in B and D, respectively, and white arrows indicate pores. 
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Figure 4-12 AFM topographical images (5.0 x 5.0 µm) of 4.0% PPI + 0.5% AL 
capsules in the absence (A), and presence (B) of P95.  Arrows indicate 
possible external pores. 
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Figure 4-13  Cryo-SEM micrographs showing the exterior surface of: 4.0% PPI + 
0.5% AL + B. adolescentis (A); and 4.0% PPI + 0.5% AL + 
B. adolescentis + P95 (B) capsules.  White arrows indicate presumptive 
B. adolescentis cells. 
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material and probiotic were homogenously mixed prior to ionic cross-linking.  The 
presence of probiotics on the surface of the capsules and the small pores observed helps 
to explain the loss in viable cell counts during capsule exposure to SGJ.  Allan-Wojtas et 
al. (2008), and Truelstrup-Hansen et al. (2002) studied the entrapment of probiotics 
within calcium-linked alginate capsules, and found visible surface impressions of 
probiotics.  The authors hypothesized that the presence of bacteria may induce localized 
gelation of the AL polymer around their outer cell membrane. 
 The external wall thickness (the wall separating the interior of the capsule from 
the external environment) of the 4.0% PPI + 0.5% AL capsules without pre- or probiotics 
was found to be 2.1  0.7 m (Table 4-4). In contrast, wall thicknesses were found to be 
lower with their addition, where capsules with B. adolescentis and B. adolescentis + P95 
had values of 0.8  0.1 and 1.2  0.2 m, respectively.  If the presence of bacteria induces 
localized gelation of the AL polymer this could decrease the amount of AL available for 
capsule formation decreasing the thickness of the external wall.  Capsules containing the 
prebiotic and the probiotic had a thicker external wall than capsules contain the probiotic 
alone (Table 4-4).  The addition of the prebiotic therefore increased the physical barrier 
to the diffusion of the SGJ into the capsules, helping to explain the increased probiotic 
survival observed with the addition of P95.  The addition of DMSO in the wall material 
solution for PPI + AL capsule production decreased the external wall thickness. 
However, with the addition of GLU-FA the wall thickness increased to measurements 
similar to those of the capsules without DMSO. 
 For comparison, the external surface of the AL capsules was examined using 
cryo-SEM.  The diameter of AL capsules observed by cryo-SEM was approximately 
2.4 mm, which was comparable to that observed by particle sizing (Table 4-1).  These 
capsules were spherical in shape and experienced no structural collapse or excessive 
shrinkage under cryo-SEM.  The surface of the AL capsules as examined by cryo-SEM 
was found to be smooth with no visible external pores.  The absence of external pores for 
the AL capsules is interesting as these capsules were unable to provide any probiotic 
  
 
80 
Table 4-4 Internal and external wall and pore sizes for AL and PPI + AL capsules. 
 Wall Thickness Pore Size  
Sample Internal  (µm) 
External  
(µm) 
Long axis 
diameter 
(µm) 
Short axis 
diameter 
(µm) 
Aspect 
ratio 
1.0% AL 
 Large pores 
 Small pores 
 0.9 ± 0.3   N/A  
85.6 ± 13.4 
14.9 ± 5.0 
 
75.9 ± 10.1 
13.0 ± 3.4 
 
 1.2 ± 0.2 
 1.2 ± 0.1 
4.0% PPI + 0.5% AL  0.4 ± 0.1  2.1 ± 0.7 13.9 ± 2.7 13.2 ± 1.6  1.2 ± 0.2 
4.0% PPI + 0.5% AL 
+ B. adolescentis 
 0.4 ± 0.1  0.8 ± 0.2 20.4 ± 7.1 18.1 ± 6.8  1.4 ± 0.3 
4.0% PPI + 0.5% AL 
+ B. adolescentis + 
P95 
 0.4 ± 0.1  1.2 ± 0.2 21.9 ± 4.9 21.1 ± 4.6  1.2 ± 0.2 
4.0% PPI + 0.5% AL 
+ DMSO 
 0.2 ± 0.1  1.4 ± 0.6 12.2 ± 3.0 10.6 ± 3.0  1.3 ± 0.4 
4.0% PPI + 0.5% AL 
+ DMSO + GLU-FA 
 Large pores 
 Small pores 
 0.5 ± 0.3   N/A  
 
15.8 ± 7.0 
 8.6 ± 3.7 
 
 
11.9 ± 4.6 
  6.5 ± 2.8 
 
 
 1.4 ± 0.3 
 1.4 ± 0.3 
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Figure 4-14  Cryo-SEM micrographs showing the exterior surface of 1.0% AL 
capsules.
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protection against the SGJ (Figure 4-4).  This indicates that the presence of external pores 
may not explain whether or not a capsule will provide probiotic protection.  It is possible 
that external pores were present but the cryo-SEM images failed to show them.  The 
external wall thickness of the AL capsules was not determined as freeze fracturing was 
unsuccessful in producing a clean edge. 
4.3.2 Examination of the internal structure of the capsules 
The internal morphology of both the 1.0% AL and 4.0% PPI + 0.5% AL capsules 
by cryo-SEM revealed a honeycomb-like structure (Figure 4-15 and Figure 4-16).  In the 
case of the AL capsules two distinct structures were evident (Table 4-4 and Figure 4-15).  
The first, consisted of large hollow honeycomb shaped pores (average short and long axis 
of 75.9 ± 10.1 and 85.6 ± 13.4 µm, respectively), whereas in the second, smaller 
honeycomb pores (average short and long axis of 13.0 to 14.9 µm, respectively) were 
present with filamentous structures inside.  The honeycombs were not of consistent 
shape, varying from rectangular to square to oval.  Both honeycomb structures had 
distinct walls separating individual pores within the internal structure.  The aspect ratio of 
the individual honeycomb pores, determined by dividing the long by the short axis 
measurements, for both the small and large pores were the same at 1.2  (Table 4-4).  The 
4.0% PPI + 0.5% AL capsules produced with or without probiotics or the synbiot, all 
exhibited a honeycomb structure.  The individual honeycomb pores were smaller than 
those observed in the 1.0% AL capsules as their long and short axis diameters ranged 
from 13.2 to 21.9 µm (Table 4-4 and Figure 4-16 A, B).  The aspect ratio of the 4.0% PPI 
+ 0.5% AL capsules was similar to the 1.0% AL capsules ranging from 1.2 to 1.4, 
indicating that the pores were slightly elongated. 
In the core of the 4.0% PPI + 0.5% AL capsules, both thick and thin filaments were 
evident within the pores (Figure 4-16 C, D).  Although filaments were seen in capsules 
with or without entrapped B. adolescentis and P95, thin filaments were more prevalent in 
the presence of the prebiotic.  The interior wall thickness for these capsules was not 
affected by the presence or absence of B. adolescentis and/or P95 and DMSO, as values 
were not significantly different (Table 4-4). 
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Figure 4-15  Cryo-SEM micrographs of the internal structures of 1.0% AL 
capsules illustrating the large hollow (A) and small filamentous 
containing (B) honeycomb pores.  The rectangle indicates the area in 
A magnified in B. 
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Figure 4-16  Cryo-SEM micrographs showing the internal structures of capsules 
composed of: 4.0% PPI + 0.5% AL + B. adolescentis (A, B); and 4.0% 
PPI + 0.5% AL + B. adolescentis + P95 (C, D). 
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The internal porous structure of the 4.0% PPI + 0.5% AL and 1.0% AL capsules 
observed with cryo-SEM agreed with those reported in literature for capsules produced 
with 2.0% (w/w) AL in a 1.0% CaCl2 solution (Zohar-Perez et al., 2004).  In this study, 
the aspect ratio determined for the internal pores were not significantly different for any 
of the capsules examined.  Although similar internal structures were observed for the 
4.0% PPI + 0.5% AL and 1.0% AL capsules, the size of the internal pores were much 
larger and less uniform in the latter.  The concentration of wall materials may have been a 
contributing factor to the size difference observed in the internal pores of the capsules.  
The concentration of the wall materials was 1.0% (w/w) for the AL, and 4.5% (w/w) for 
the PPI + AL capsules, respectively.   
The thick filamentous structures observed within the pores of the 4.0% PPI + 
0.5% AL capsules are thought to arise from the commercial pea protein isolate material 
as they were not present in the capsules comprised of AL alone.  These structures could 
consist of protein, fiber and/or carbohydrate as these compounds were all present at 
relatively high concentration in the starting material.  The thin filamentous structures 
were observed in all the capsules but were more prevalent in the capsules containing P95 
and are thought to be artifacts of salts or carbohydrates created by the cryo-SEM 
technique.  Published research examining artifacts created by cryo-SEM have reported 
that solutions commonly used as storage reagents, such as sucrose, tris and NaCl, 
produced filament-like structures when observed under cryo-SEM (Miller et al., 1983).  
Also, fibrillar networks and membranous structures have been observed in sugar 
solutions ranging in concentration from 2 to 50 mM (Moss et al., 1989).  These structures 
form as a result of ice crystal growth for soluble compounds that concentrate between the 
crystals, forming a network of eutectic regions.  When the ice is sublimed, it leaves 
behind the less volatile eutectic regions and produces a lattice-like appearance (Moss et 
al., 1989).   
4.3.3 Prebiotic and probiotic distribution within the capsules 
Bifidobacterium adolescentis were found to be present on the external surface of 
capsules and within the internal honeycomb pores as determined by cryo-SEM  
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(Figures 4-13 and 4-17).  The presence of probiotics within the internal pores of the 
biopolymer-based capsules has been reported by others (Sultana et al., 2000; Truelstrup-
Hansen et al., 2002; Allan-Wojtas et al., 2008).  The use of CLSM to observe probiotic 
distribution within the capsules was unsuccessful because both the PPI + AL matrix and 
B. adolescentis labeled with PI were excited at 488 nm and emitted light at the same 
bandwidth (610-675 nm, Figure 4-18).  This created background fluorescence that made 
it impossible to distinguish probiotic cells from the capsule matrix.   
Visualization of the distribution of prebiotic within the 4.0% PPI + 0.5% AL 
capsules was accomplished by fluorescent tagging (FA) of the carbohydrate prior to 
CLSM analysis.  Glucose was used in these studies because of the better water solubility 
of the GLU-FA derivative compared to P95.  Also, the molecular mass of GLU-FA 
(~530 g mol-1) is approximately the same as that of a DP 3 FOS, which was the most 
abundant oligosaccharide present in P95 (Table 4-2).  The fact that glucose had similar 
chemical/reaction properties (reducing carbohydrate; conversion to an amine via 
reductive amination) to P95 also supported its use.Preliminary work involved a reductive 
amination reaction with glucose and FA (glu-FA), where FA was employed as the 
limiting reagent (4:1, glucose to FA).  Thin layer chromatography (TLC) of the reaction 
mixture showed no unbound FA.  The lowest concentration of FA to be visualized by 
TLC was 0.005 M.  The GLU-FA (0.3% w/w) was encapsulated without purification 
(impure GLU-FA) within the 4.0% PPI + 0.5% AL capsule; in addition the same protein-
based capsules were prepared with 0.005M FA.  CLSM images of representative capsules 
showed fluorescence for each which was homogeneously distributed (Figure 4-19).  
Based on these results, it was unclear whether the fluorescence within the protein-based 
capsules was due to the GLU-FA or unbound FA.  However, these experiments showed 
that background fluorescence of the protein-based + DMSO was negligible (Figure 4-19).  
A GLU-FA sample was produced using glucose as the limiting reagent (5:1, FA to 
glucose) so as to reduce the concentration of unbound FA in the reaction mixture.  
Chromatographic separation was used to isolate GLU-FA from FA, and this purified 
material was used in subsequent protein-based + prebiotic encapsulation experiments.  
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Figure 4-17 Cryo-SEM micrographs showing the presence of bacteria in capsules 
composed of: 4.0% PPI + 0.5% AL + B. adolescentis (A,B); and 4.0% 
PPI + 0.5% AL + B. adolescentis + P95 (C).  White arrows indicate 
B. adolescentis cells. 
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Figure 4-18  CLSM images of: B. adolescentis labelled with PI (A); 4.0% PPI + 0.5% AL capsules (B); and 4.0% PPI + 0.5% 
AL + B. adolescentis labelled with PI (C) capsules.  Images taken with a 40x objective lens, attentuation, 
brightness and contrast for all images were the same. λex = 488 nm λem = 573-647 nm 
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Figure 4-19  CLSM images of capsules comprised of: 4.0% PPI + 0.5% AL + impure GLU-FA (A); 4.0% PPI + 0.5% AL + 
0.005 M FA (B) and 4.0% PPI + 0.5% AL + DMSO (C).  Attenuation, brightness and contrast for all images 
were the same. λex = 488 nm λem = 495-525 nm. 
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Images (CLSM) of 4.0% PPI + 0.5% AL + DMSO + GLU-FA capsules showed 
fluorescence throughout, as cross sections near the top/bottom and middle of the capsules 
all showed fluorescence (Figure 4-20).  These results indicated that GLU-FA was 
distributed throughout the capsule. 
However, the GLU-FA was not completely soluble in the 4.0% PPI + 0.5% AL 
solution, therefore DMSO was added to solubilize this derivative.  The addition of 
DMSO resulted in changes to the structure of the protein-based capsules, in that the 
external walls were more porous, there was some flattening of the internal pores and 
these pores were smaller (Figure 4-21 and Table 4-4) than those without added DMSO.  
These results indicated that the presence of DMSO in the amount used (0.4 g or 16.7%) 
to solublize the GLU-FA impacted capsule structure.  When DMSO was added at 
concentrations >50%, the wall material gelled, however, this phenomenon was not 
observed at the 16.7% concentration used in this study.  Studies have shown that DMSO 
can affect proteins when used at high and low concentrations.  A study examining DMSO 
concentrations (0.1 to 5% (v/v)) on a human growth hormone receptor and the 
phosphatase domain of PFKFB1 found that it could change the properties of proteins in 
solution, leading to protein denaturation, aggregation or degradation (Tjernberg et al., 
2005). Therefore, structural changes and aggregation of PPI in 16.7% DMSO could have 
occurred prior to complexation with CaCl2 affecting capsule structure. 
In contrast, the addition of DMSO did not significantly change the internal wall 
thickness or aspect ratio of the internal pores (Table 4-4).  The 4.0% PPI + 0.5% AL + 
DMSO ± GLU-FA capsules also had the same spherical shape and capsule diameter (1.7 
to 2.0 µm) as the protein-based capsules without DMSO.  It was assumed that P95 would 
have the same distribution within the PPI + AL capsules as seen with GLU-FA.  The 
even distribution of the GLU-FA in the capsules show that P95 would also be evenly 
distributed throughout the capsule wall, making the prebiotic readily available to the 
probiotic as a carbon source to promote growth. 
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Figure 4-20  CLSM images of 4.0% PPI + 0.5% AL + DMSO + GLU-FA capsules 
showing carbohydrate distribution in centre cross-sections (A, B, and 
D) and peripheral cross-section (C) of the capsules.  Images were 
taken with a 10x objective lens. λex = 488 nm λem = 495-525 nm. 
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Figure 4-21 Cryo-SEM micrographs showing the porous external surface of 4.0% 
PPI + 0.5% AL + DMSO + GLU-FA (A) and the flattening of the 
internal pores of 4.0% PPI + 0.5% AL + DMSO (B), capsules. 
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4.3.4 Summary and conclusions 
The external and internal morphologies of the 4.0% PPI + 0.55 AL capsules were 
examined to better understand the encapsulation matrix and its ability to protect 
B. adolescentis against the harsh conditions in the GI tract.  The external surface of the 
4.0% PPI + 0.5% AL capsules as determined by cryo-SEM and AFM showed a relatively 
smooth surface with the presence of pores.  The presence of these surface pores indicated 
that gastric juices would be able to penetrate the surface of the capsules and could 
potentially destroy encapsulated probiotics. 
The internal structure of the 4.0% PPI + 0.5% AL capsules was observed using 
cryo-SEM; alginate capsules were observed for comparison.  A porous honeycomb 
internal structure was observed for both the 1.0% AL and 4.0% PPI + 0.5% AL capsules 
with the AL capsules having larger internal diameters than the PPI + AL capsules.  The 
large internal pores of the AL capsules helped to explain why no survival of 
B. adolescentis was observed with this wall material. If SGJ entered the capsules through 
the pores on the external surface then diffusion through the AL capsule internal matrix 
would be faster due to their larger internal diameter. 
Bifidobacterium adolescentis cells were randomly distributed on the external 
surface and within the internal pores of the capsules.  Fluorescently tagged glucose 
encapsulated in the PPI + AL capsules as observed by CLSM showed fluorescence 
throughout the capsule matrix. This result indicated that the prebiotic would be in the 
vicinity of the probiotic and would be available for use as a growth substrate. 
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5. Conclusions 
Although encapsulation of probiotics to improve survival in SGJ has been 
extensively researched in literature, the examination of WPI-AL and PPI-AL as wall 
materials have not.  The use of protein-based capsules by extrusion was shown to provide 
excellent protection to B. adolescentis, as numbers were only reduced by 1.1 and 3.6 log 
CFU mL-1 in SGJ at pH 2.0 for 2 h whereas capsules produced from AL alone showed no 
survival.  The increase in probiotic survival exhibited by the protein-based capsules over 
AL was due in part to their having a higher wall material concentration, 4.5% for the 
protein-based capsules and 1.0% for the AL capsules, and a smoother, less porous 
external surface as shown by SEM.   The higher wall material concentration and the less 
porous nature of the protein-AL capsules indicated that the diffusion of SGJ into these 
capsules would be slower than in the case of the AL capsules.  The creation of a capsule 
that successfully protects probiotics from the acidic environment of the stomach is 
important to allow for the delivery of probiotic strains associated with health benefits 
rather than the delivery of probiotic strains associated with increased acid resistance. 
The size of the capsules was also determined to be a possible factor in probiotic 
survival.  Capsules composed of 4.0% WPI + 0.5% AL were produced by the emulsion 
and the extrusion methods of encapsulation.  The emulsion capsule had a geometric mean 
diameter of 53 µm and the extrusion capsules had a geometric mean diameter of 2.2 mm.  
The emulsion produced capsules showed no probiotic survival.  Reducing capsule size to 
where the texture/sensory of a food would not be adversely affected, as in the case for the 
emulsion capsules, removed the capsule`s ability to protect the probiotic against SGJ.  
Another factor that could potentially be a factor in probiotic survival is the structure of 
the capsule.  The structure of the emulsion-based capsules may have been different from 
the extrusion-based capsules therefore allow SGJ to penetrate the capsules more readily. 
Bifibacterium adolescentis was found to have a significantly higher growth rate with 
P95 than with glucose.  The growth of the probiotic on P95 and Syn was a result of 
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oligosaccharide and monosacharride utilization as determined by HPAE-PAD.  Growth 
rates of probiotics with prebiotics have been studied; however, the ability of a probiotic 
to utilise a monosaccharide free oligosaccharide source had yet to be researched.  
Results of this study showed B. adolescentis is capable of utilizing glucose-free 
maltooligosaccharides as a carbon source. 
The probiotic and prebiotic were encapsulated by extrusion in 1.0% AL + P95 and 
4.0% PPI and 4.0% WPI + 0.5% AL + P95 with a final carbohydrate concentration of 4.0 
to 4.4 mg per gram of capsules, although exhibited low retention (<15%).  The addition 
of P95 into the capsules resulted in improved survival for the 4.0% PPI + 0.5% AL 
capsules in SGJ at pH 2.0 for 2 h.  It is important to deliver the prebiotic in an 
encapsulated form along with the probiotic to ensure that they are in proximity to one 
another and to decrease acidic hydrolyse of the prebiotic.  This research was able to 
create a possible synbiot to improve probiotic survival in SGJ at pH 2.0.  The creation of 
a successful synbiot can be stated if the availability of the encapsulated P95 was 
determined.   
Extrusion-based capsules employing 4.0% PPI + 0.5% AL were examined for their 
morphological properties and prebiotic and probiotic distribution.  Morphological studies 
using cryo-SEM and AFM showed that the protein-based capsules had small surface 
pores (0.25 to 1.0 µm in diameter).  The addition of P95 and B. adolescentis appeared to 
have no effect on the external surface of the capsules.  The internal structure of the 4.0% 
PPI + 0.5% AL capsules was observed to have a porous honeycomb structure with 
internal pore diameters ranging for 13.2 to 21.9 µm.  Alginate capsules viewed under 
cryo-SEM showed a porous honeycomb structure with two internal pore sizes; one large 
(75.9 to 85.6 µm) and one small (13.0 to 14.9 µm).  The presence of pores on the external 
surface and the smaller internal porous structure of the 4.0% PPI + 0.5% AL capsules 
helps explain the increased probiotic survival observed when compared to the AL 
capsules.  The SGJ entering the capsules through the small external pores would diffuse 
more rapidly throughout the AL capsule with large internal pores than through the 
protein-based capsule with small internal pores.  The distribution of the probiotic and 
prebiotic was found to be randomly and evenly distributed throughout the capsules, 
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respectively.  This indicates that the probiotic would have access to the prebiotic for 
growth. 
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6. Future Directions 
This study has shown that the production of extrusion-based capsules composed of 
WPI + AL and PPI + AL shows much promise for increasing probiotic survival in SGJ at 
pH 2.0.  It has also shown that P95 can be added to create a synbiot in concentrations that 
could facilitate growth of the probiotic.  However, the availability of the P95 to the 
probiotics was not determined.  The P95 may have been incorporated into the wall 
structure making it unaavailbale.  To confirm the successful creation of a synbiot access 
to the encapsulated P95 must be determine.  Also the amount of P95 encapsulated was 
<15% and would not be commercially viable, therefore ways to increase the amount of 
P95 encapsulated must be investigated.  A potential approach would be to add P95 to the 
cross-linking solution at a concentration desired within in the capsule to prevent the 
diffusion of the P95 out along the concentration gradient. 
Morphological studies showed that the prebiotic and probiotic would be in close 
proximity and the internal small pore honeycomb structure of the 4.0% PPI + 0.5% AL 
capsules help explain the increase in probiotic survival of this wall material when 
compared to AL alone.  With this data, it would be valuable to investigate ways to 
decrease the size of the extrusion-based capsules by using a smaller gauge needle or 
changing the polymer concentration.  Also morphological studies determined the 
structure of the extrusion-produced capsules, and it would be valuable to determine the 
structure of the emulsion-produced capsules to determine the extent of size and structure 
on the capsules ability to protect the probiotic.   
Although this study examined probiotic survival in SGJ, no research was conducted 
on the ability of these capsules to provide protection against the bile acids present in the 
small intestine.  In addition, probiotic and prebiotic release from the capsules were not 
investigated.  These two studies would provide valuable information on whether not these 
capsules could deliver and release the active ingredients to their target destination.  These 
studies could be conducted in vivo with the use of a simulator of the human intestinal 
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microbial ecosystem (SHIME).  Also the investigation of these capsules in an animal 
model would be very useful if one was to market the capsules as an animal feed 
supplement instead of a functional food ingredient.  
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